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Abstract 
Propagation of Plasmodium parasites within erythrocytes is responsible for the majority of the 
symptoms associated with the human malaria disease. Survival of these parasites relies on 
remodelling of their host cells via exported proteins. These proteins are trafficked to various locations 
within the host cell in order to fulfil their function. In particular, the causative agent of the most virulent 
form of the human malaria disease –P. falciparum– is known to introduce drastic changes of their 
infected host cells. Investigation of parasite genes implicated in host cell remodelling and protein 
trafficking is critical for our understanding of the disease and might open up novel ways to combat 
malaria. However, analysis of essential genes involved in these processes requires the use of 
conditional knockout or knockdown system. Despite this there was a prolonged lack of genetic 
systems suitable to interrogate essential P. falciparum genes until recently, when several new systems 
were introduced. This includes the promising new glmS system which enables knockdown of a 
modified gene through the self-cleaving action of the glmS ribozyme triggered by addition of 
glucosamine. Here we apply glmS for conditional downregulation of four P. falciparum genes: 
PFA0660w, GEXP18, CBP1 and PfJ23. PFA0660w was modified using conventional single-crossover 
recombination, while modification of the other three genes was executed via selection-linked-
integration, a new system for integration into the P. falciparum genome. PFA0660w, CBP1 and PfJ23 
were successfully modified with a glmS-sequence and enabled reliable glucosamine-dependent 
downregulation. Modification of GEXP18 coincided with retention of the wild-type GEXP18 locus, 
which meant that these cell lines could not be used in further experiments. The cell lines generated by 
selection-linked-integration also displayed signs indicative of malfunction of the SKIP peptide. Addition 
of glucosamine to the glmS-modified PFA0660w, CBP1 and PfJ23 cell lines enabled downregulation 
of protein abundance to ~10% of the non-treated control. This had no effects on parasite morphology 
and viability. Furthermore, no differences in knob-morphology upon downregulation of PFA0660w or 
CBP1 were observed. Also downregulation of PFA0660w did not induce changes in parasite 
cytoadhesion. However, inactivation of PFA0660w via severe truncation caused drastically deformed, 
elongated knob morphologies. This demonstrates that the downregulation of PFA0660w achieved via 
glmS was not strong enough to cause the observed mutant phenotype upon truncation. Overall 
effectivity of the glmS system seemed to be highly gene-specific and should therefore be restricted to 
high-priority targets. Also alternative systems should be considered for the further dissection of 
essential P. falciparum genes. Truncation of PFA0660w induced fascinating changes in infected red 
blood cell morphology which could be further dissected using high-resolution microscopy methods. 
  
 
 
Zusammenfassung 
Die Mehrzahl an Symptomen assoziiert mit klinischer Malaria ist auf die Vermehrung von Parasiten 
der Gattung Plasmodium im Inneren von Erythrozyten des Wirts zurückzuführen. Das Überleben 
dieser Parasiten hängt davon ab ihre Wirtszelle mittels exportierter Proteine zu modifizieren. 
Besonders der Erreger der virulentesten Form der Malaria –P. falciparum– ist dafür bekannt 
besonders drastische Veränderungen vorzunehmen. Die Erforschung dieser exportierten Proteine ist 
ausschlaggebend für unser Verständnis von Malaria und könnte neuartige Bekämpfungsstrategien 
eröffnen. Die Analyse von essentiellen Genen involviert in Protein Transport und Wirtszellmodifikation 
erfordert jedoch den Gebrauch von konditionellen „Knockout“ und „Knockdown“ Systemen. Lange Zeit 
stand kein solches System zur Verfügung, was die Forschung in diesem Bereich erschwerte. Jetzt 
wurden allerdings einige neue Systeme vorgestellt, unter anderem auch das vielversprechende glmS-
System, welches auf der autokatalytischen Spaltung des glmS Ribozymes ausgelöst von Glucosamin 
basiert. In dieser Arbeit wurden die P. falciparum Gene PFA0660w, GEXP18, CBP1 und PfJ23 für die 
Analyse mit glmS ausgewählt. PFA0660w wurde mittels konventioneller, homologer Rekombination 
modifiziert, während die drei verbleibenden Gene mittels eines neuen Systems zur genetischen 
Veränderung des P. falciparum Genoms editiert wurden: „Selection-linked-Integration“. Drei Gene 
(PFA0660w, CBP1 und PfJ23) wurden erfolgreich. Modifikation von GEXP18 zog jedoch Retention 
des Wildtyp GEXP18 Lokus nach sich, daher konnten diese Parasiten nicht für folgende Experimente 
benutzt werden. Beide Zelllinien die mittels „Selection-linked-integration“ erstellt wurden deuteten 
außerdem auf Störungen des SKIP-Peptids hin. Durch Zugabe von Glucosamin zu den glmS Ziellinien 
von PFA0660w, CBP1 und PfJ23 wurde eine Herunterregulation der Proteinabundanz auf ~10% 
verglichen mit unbehandelten Parasiten erzielt. Dies hatte keinen Effekt auf die Morphologie und das 
Überleben der Parasiten. Außerdem wurden keinen Veränderungen in der „Knob“ Morphologie durch 
Regulation von PFA0660w oder CBP1 festgestellt. Zusätzlich hatte die Regulation von PFA0660w 
keinen Effekt auf die Zytoadhärenz der Parasiten. Inaktivierung von PFA0660w zog jedoch drastische 
Fehlbildungen der „Knobs“ auf infizierten Erythrozyten nach sich. Das lässt darauf schließen, dass die 
Regulation die mit dem glmS System erreicht wurde nicht stark genug war um diesen mutanten 
Phänotyp hervorzurufen. Generell scheint die Effektivität des glmS-Systems sehr Gen-spezifisch zu 
sein, daher sollte es nur für die Analyse von Genen mit hoher Priorität verwendet werden. Zusätzlich 
könnten alternative Systeme für die Analyse von essentiellen P. falciparum Genen erprobt werden. 
Inaktivierung von PFA0660w zog faszinierende Änderungen der „Knob“ Morphologe nach sich. 
Zukünftige Experimente könnten diesen Phänotyp weiter charakterisieren zum Beispiel mittels 
hochauflösender Mikroskopie-Verfahren.  
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1 Introduction 
1.1 The phylum of the Apicomplexa 
Several hundred million years past the last common ancestor of the Apicomplexa developed a 
parasitic life style. Loss of photosynthesis and flagella as well as gain of a new motility apparatus, 
invasion and immune-evasion related genes transformed this free living phototrophic marine algae into 
a vast and diverse phylum of unicellular, obligate intracellular parasites (White & Suvorova 2018; Woo 
et al. 2015). Today the Apicomplexa encompass 6000 species with potential millions still left to 
uncover (Adl et al. 2007). As eukaryotes they show a complex intracellular organisation (Figure 1), 
including a nucleus, endoplasmic reticulum (ER), Golgi apparatus and mitochondria. The Apicomplexa 
are named according to a special set of secretory organelles in the invasive stages (Cowman et al. 
2012; Morrissette 2002). The secretory organelles micronemes, rhoptries and dense granules release 
their contents sequentially to facilitate processes like host cell invasion, egress and remodelling 
(Dubois & Soldati‐Favre 2019). Furthermore most Apicomplexa share features like a non-
photosynthetic chloroplast termed apicoplast and a class of plant-like transcription factors called 
ApiAP2 (Balaji et al. 2005; Iyer et al. 2008; McFadden et al. 1996). As masters of host cell 
manipulation and immune evasion, Apicomplexa exhibit a wide host range including invertebrates, 
birds and mammals. Infections by apicomplexan parasites are responsible for a considerable health 
Figure 1: Complex intracellular organization of an apicomplexan Plasmodium parasite in the invasive merozoite 
stage. The conventional set of apicomplexan secretory organelles is extended with the addition of dense-granule 
like exonemes. The inner membrane complex is and endomembrane system involved in motility, which is 
underlined by sub-pellicular microtubules anchored to apical polar rings (Cowman et al. 2012). 
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burden as well as economic loss through the infection of livestock. Prominent members include human 
infecting Plasmodium, Toxoplasma and Cryptosporidium parasites as well as cattle and poultry-
infecting Theileria and Eimeria parasites (Blackman & Bannister 2001; Plattner & Soldati-Favre 2008). 
One third of the human population is infected by the extremely successful and ubiquitous parasite 
Toxoplasma gondii which can cause toxoplasmosis in immunocompromised individuals, while 
Cryptosporidium parvum is an important agent of gastrointestinal illness (Corso et al. 2003; Tenter et 
al. 2000). Plasmodium parasites cause by far the highest human death-toll, since they are responsible 
for the malaria disease (WHO 2018). Therefore our understanding of the fascinating cell biology of 
these parasites is critical to human health and wellbeing. 
 
1.2 Plasmodium parasites 
The ~two hundred known Plasmodium parasites are transmitted by various mosquito-species to 
intermediate vertebrate hosts, including amphibians, birds, rodents, primates and humans (Bruce-
Chwatt 1993; Levine 1988). The human infecting species Plasmodium falciparum, P. knowlesi, 
P. malariae, P. vivax  as well as P. ovale with the two subspecies P. ovale curtisi as well as 
P. ovale wallikeri use Anopheles mosquitoes as vectors and are the causative agent of the malaria 
disease (Ashley & Phyo 2018; Singh et al. 2004; WHO 2018). Interestingly, human P. falciparum 
infection was acquired relatively recent (past 10.000 years) from Gorilla species (Liu et al. 2010; 
Sundararaman et al. 2016). This is also reflected in the genealogy of the parasites as P. falciparum in 
contrast to other human infecting Plasmodia belongs the Laverania, a subgenus of primate-infecting 
Plasmodia which differs from other human infecting Plasmodia in life cycle and gametocyte 
morphology (Bray 1958; Coatney & Collins 1971). All Plasmodia follow a complex life cycle with 
multiple stages in the vertebrate and invertebrate host (Figure 2) featuring exogenous sexual and 
asexual stages within the mosquito as well as asexual proliferation within liver and red blood cells of 
the vertebrate host (Sinnis et al. 1994). The cycle begins, when immature male and female haploid 
Figure 2: The complex life cycle of Plasmodium parasites features exogenous sexual and asexual stages within 
the mosquito as well as asexual proliferation in hepatocytes of the liver and RBCs in the vertebrate host (Su et al. 
2007). 
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sexual stages of the parasites are taken up by the mosquito during a blood meal (Su et al. 2007). 
Changes in i.a. temperature and solutes in the mosquito midgut causes these gametocytes to exit their 
vertebrate red blood cell (RBC) host cell and differentiate into micro and macrogametes. 
Microgametes then exflaggelate, seek out and fertilize macrogametes to give rise to diploid zygotes, 
which then undergo meiosis and differentiate into ookinetes containing four haploid genomes. These 
mobile invasive forms migrate though the midgut lumen, the protective peritrophic matrix as well as 
through epithelial cells of the mosquitos gut. There they bind to the basal lamina of the digestive organ 
of the mosquito and differentiate into immobile, replicative stages called oocysts. Oocysts feed on the 
mosquito’s circulatory fluid, the hemolymph to fuel their rapid development. After eight to fifteen days, 
depending on the parasite species oocysts release thousands of mobile, haploid sporozoites which 
are transported via the hemolymph throughout the body cavity of the mosquito. Interaction with 
unknown factors of the salivary glands causes their retention. Sporozoites traverse the basal lamina 
which is covering the glands as well as secretory cells to accumulate within the salivary cavity from 
where they gain access to the proboscis of the mosquito via the salivary ducts (Garcia et al. 2006; 
Pimenta et al. 1994; Sterling et al. 1973). Transmission to a vertebrate host is initialized through the 
bite of an infected mosquito leading to the inoculation of twenty to two-hundred sporozoites into the 
skin, which then actively migrate at high speed through several layers of cells into blood of lymphatic 
vessels (Amino et al. 2006, 2008; Garcia et al. 2006). The parasites then migrate to the liver, where 
they are retained to start the first phase of asexual proliferation in the vertebrate host. First parasites 
cross endothelial and resident liver macrophages termed Kupffer cells of the sinusoidal cell layer to 
invade and propagate inside of hepatocytes (Danforth et al. 1980; Frevert et al. 2005; Shin et al. 1982; 
Vanderberg & Frevert 2004). After 6-15 days, depending on the species, thousands of merozoites are 
released into the bloodstream sheltered from the hosts immune system inside of hepatocyte derived 
vesicles called merosomes to initiate the second phase of asexual proliferation in the vertebrate host 
(Shortt et al. 1951; Sturm et al. 2006). Some parasite species (notably P. vivax and P. ovale) can also 
form uninucleated, latent liver stages. These hypnozoites can resume development, weeks, months or 
even years after successful treatment of blood stage parasites causing relapse of the infection (Bruce-
Chwatt 1993). In the erythrocytic cycle the parasites invade erythrocytes and develop though ring, 
trophozoite and schizont stages to release ~16-32 new merozoites (Bannister & Mitchell 2003). 
Intensive feeding and growth during the trophozoite stage culminate in nuclear divisions and the 
formation of daughter cells during the schizont stage. These daughter merozoites are released with 
the help of a cascade of parasite proteases and invade a fresh RBC after a brief extracellular phase 
(Bannister & Mitchell 2003; Salmon et al. 2001; Thomas et al. 2018).  Each round of replication can 
take one (P. knowlesi), two (P. falciparum, P. vivax and P. ovale) or three days (P. malariae). Some of 
the asexual forms enter the sexual cycle and differentiate in a 7-10 days long process over five stages 
(P. falciparum) into mature gametocytes (Su et al. 2007). Immature gametocytes (stage I-IV) are 
sequestered in areas which may provide protection from the host’s immune system such as the bone 
marrow. Mature stage V gametocytes then re-enter the bloodstream and are then taken up by a  
mosquito to complete the cycle (Garcia et al. 2006; Gardiner & Trenholme 2015; Tiburcio et al. 2012). 
Propagation of Plasmodium parasites during the blood stage of the infection is responsible for the 
majority of the symptoms associated with the malaria disease (WHO 1990). 
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1.3 The malaria disease 
Historical accounts of malaria-like sickness have been found in ancient texts from Africa, China, 
Europe, India and the Middle East, with some of them even predating 4000 years (Carter & Mendis 
2002). Occurrence of the disease was first linked to “miasmas” arising from swamps, which may have 
played a part in the naming of the disease according to the Italian word for “spoiled air”: mal'aria. 
Today we know that human malaria is an infectious disease caused by apicomplexan parasites of the 
genus Plasmodium which are transmitted via Anopheles mosquitoes, thanks to discovery of the 
parasites by Charles Louis Alphonse Laveran in 1880 and identification of the mosquito vectors by 
Giovanni Battista Grassi, Amico Bignami, Giuseppe Bastianelli, Angelo Celli, Camillo Golgi and Ettore 
Marchiafava between 1898 and 1900 (Cox 2010). Of the five human infecting species P. falciparum 
and P. vivax are responsible for the highest morbidity. In contrast to P. vivax, P. falciparum is the 
causative agent of the severest form of malaria, malaria tropica and therefore responsible for most of 
the malaria-associated mortality. Progression of the tertian malaria caused by P. vivax is generally 
less severe but still remains responsible for significant morbidity because of its high prevalence. 
Therefore, these species are main targets of eradication efforts. P. falciparum is the main cause of 
malaria in Africa, South-East Asia, the eastern Mediterranean as well as the Western Pacific regions, 
P. vivax infection is most prevalent in the Americas (Anstey et al. 2012; Maier et al. 2018; WHO 2018). 
Rapid multiplication of blood stage-parasites can lead to up to 10
12
 parasites in a patient’s 
bloodstream and high-parasitemias of >4%. Malaria disease severity ranges from asymptomatic to 
rapidly progressive, fatal illness depending on age, immune and pregnancy status of the host and also 
species and genotype of the parasite. The most affected group are children under the age of five 
years and pregnant women (Desai et al. 2007; WHO 2018).  Common symptoms during mild malaria 
include headache, coughing, chills and fever, which may be accompanied by nausea, vomiting, 
diarrhea and abdominal pain. Severe malaria cases exhibit respiratory distress, anaemia and 
hypoglycaemia or even reduced consciousness, coma and death in patients with the severest form of 
Figure 3: Global distribution of malaria in 2017. Even though more and more countries are being declared 
malaria-free the disease remains prevalent in in Africa, South-East Asia, the eastern Mediterranean as well as the 
Western Pacific regions (P. falciparum) and in the Americas (P. vivax) (WHO 2018). 
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malaria: cerebral malaria (Weatherall et al. 2002). Human migration around the world was 
accompanied by spread of the parasites which also left deep marks in the human genome (Carter & 
Mendis 2002). Evolutionary pressure caused by the disease is likely responsible for the emergence of 
haemoglobinopathies in some areas of the world (Cavalli-Sforza et al. 1994). Notably the sickle cell 
trait is caused by a single point mutation in the beta chain of haemoglobin and leads to RBC 
deformation (Livingstone & Marks 2019). Heterozygote carriers of the gene display signification 
protection against malaria, which is therefore highly prevalent in the African region. In contrast 
homozygotes suffer severe sickle cell anaemia (Gilles et al. 1967; Hill et al. 1991). Further mentions of 
hereditary haemoglobinopathies retained in the human population due to a protective effect from 
malaria include thalassemia, G6PD deficiencies and ovalocytoses. The toll of these genetic burdens 
imposed by the parasites should not be forgotten when assessing the impact of these parasites on 
human health (Carter & Mendis 2002). There were an estimated worldwide 219 million clinical malaria 
cases in 2017 resulting in 435.000 deaths with almost 80% occurring in sub-Saharan Africa and India. 
Since 2010 there has been significant reduction in the global malaria burden with now more and more 
countries being declared “malaria free” (Figure 3). Despite these promising signs progress towards 
eradication of malaria was stalled in the recent years. It seems that the world is off track to achieve the 
set goal to reduce malaria disease and deaths by at least 40% until 2020. With resistance against the 
major antimalarial artemisinin as well as insecticides used against the transmitting mosquitoes 
spreading these aims are even more under threat (WHO 2018). Artemisinin-combination therapies 
combine the fast-acting, highly effective but rapidly eliminated artemisinin with a more stable partner 
drug like piperaquine to eliminate P. falciparum infection (White 1999). Rise and spread of artemisinin 
resistance in Southeast Asia is of growing concern, as this also puts more strain on the partner drugs 
with the result of partner drug resistance (Ashley & Phyo 2018). While modern Artemisinin-
combination therapies remain effective, this still highlights the importance of understanding the 
parasites biology to develop new ways to combat this devastating disease.  
 
1.4 P. falciparum induced host cell remodelling 
The main function of erythrocytes during their 120 days life-span is the delivery of O2 to the peripheral 
tissues and the evacuation of CO2. To fulfil this task, mature, biconcave erythrocytes are anucleated 
and devoid of any intracellular compartments. Instead they feature large amounts (96% of dry content) 
of the O2 and CO2 transport protein haemoglobin as well as a very flexible and strong cytoskeleton, 
which allows these cells to undergo massive deformations during their travel through the circulatory 
system (Gronowicz et al. 1984; Kuhn et al. 2017; Smith 1987; Yu et al. 1973). During blood-stage 
Malaria Plasmodium parasites propagate within these RBCs. Since RBCs are not major 
histocompatibility complex I presenting  they thus cunningly escape the hosts immune system (Brown 
et al. 1979). However this also provides some challenges for the parasite, as it cannot hijack functions 
of its host cell to suit its own needs (Gunalan et al. 2013). Instead it largely depends on remodelling of 
its host cell to promote its own survival in this unwelcoming environment. Particularly P. falciparum is 
known for its ability to radically modify their vertebrate host cell, which is likely the cause of the 
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increased virulence of this parasite species and therefore constitutes a prime focus of research. This 
extraordinary feat is achieved with the help of hundreds of parasite proteins exported to various 
compartments within the infected host cell and its membrane (Hiller et al. 2004; Marti et al. 2005). In 
its first challenge the parasite must actively enter its host cell. Initial random binding of any part of a 
merozoite triggers waves of RBC deformations, which are followed by reorientation of the merozoite 
until its anterior end faces the RBC surface. Subsequent release of protein contents from the rhoptries 
and micronemes causes the indentation of the RBC surface as well as the formation of a tight junction 
between the parasite and it’s to-be host cell (Gunalan et al. 2013). Movement of this junction from the 
anterior end of the merozoite to its posterior end leads to internalization of the parasite. This is results 
in brakeage of the tight junction and resealing of the RBC membrane (Dvorak et al. 1975; Gaur & 
Chitnis 2011; Gilson & Crabb 2009). Upon entry into its host cell the parasite engulfs itself within a so-
called parasitophorous vacuole (PV), which shelters the parasite from the host cell cytoplasm as well 
as acidification and is retained during its whole life cycle (Figure 4) (Haldar 2016; Scholtyseck & 
Piekarski 1965; Schwartzman & Saffer 1992). On the other hand the parasitophorous vacuole 
membrane (PVM) constitutes another barriers that must be crossed by exported proteins and imported 
Figure 4: P. falciparum parasites reside within a parasitophorous vacuole within their RBC host cell. Export of 
parasite proteins across the parasite plasma membrane and the adjacent PVM into the infected erythrocyte 
enables remodelling of the host cell. Entry of parasite proteins into the secretory system is governed by recessed 
hydrophobic N-terminal signals. The default target of secreted parasite proteins is the lumen of the PV. For the 
majority of exported parasite proteins export beyond the confines of the PV is enabled by a PEXEL sequence 
which is cleaved by Plasmepsin V in the ER. A smaller group of exported proteins –referred to as PNEPs– is 
trafficked to the iRBC despite lack of a PEXEL sequence. Both PEXEL and PNEP proteins are translocated into 
the cytosol of the host cell via the PTEX translocon and trafficked to their respective final destinations like 
Maurer´s clefts, J-dots, RBC cytosol or knobs. This facilitates virulence associated functions like cytoadhesion 
and antigenic variation (Bullen et al. 2012). 
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nutrients (Lanners et al. 1999; Przyborski et al. 2016). Haemoglobin is the major nutritional source 
inside of RBC for Plasmodium only supplies limited quantities of the amino acids cysteine, glutamate, 
methionine, proline, as well as tyrosine and completely lacks isoleucine (Divo et al. 1985; Guidotti et 
al. 1962; Hill et al. 1962). In order to obtain these and other essential nutrients like sugars, 
nucleosides and inorganic ions the parasite induces new permeability pathways in its host cell allowing 
the exchange of these molecules (Ginsburg et al. 1983).  
After entry into its host cell the parasite must face its second challenge: establishment of a protein 
trafficking systems to allow refurbishment of its new host cell (Figure 4). While the exact functionality 
of this system remains elusive, several key- components like J-dots and Maurer´s clefts have been 
identified. Maurer´s clefts are formed early after invasion and appear as parasite-derived flattened 
vacuoles limited with one plasma membrane beneath the RBCs surface and a length of ~500 nm 
(Figure 5) (Atkinson & Aikawa 1990; Henrich et al. 2009; Langreth et al. 1978; Maurer 1902). However 
they do vary in morphology between different laboratory strains (Hanssen et al. 2007; Wickert et al. 
2004). Maurer´s clefts are believed to originate from the PVM and seem to be interconnected with 
each other, the erythrocyte membrane as well as the PVM, consistent with their role as protein sorting 
and complex assembly stations (Atkinson et al. 1987; Atkinson & Aikawa 1990; Hanssen et al. 2007; 
Kara et al. 1988; Mundwiler-Pachlatko & Beck 2013; Wickert et al. 2003; Wickert et al. 2004). 
Maurer´s clefts are attached to the RBC membrane via 25 nm by 200 nm tube-like structures called 
tethers (Hanssen et al. 2007). Two sets of vesicles that are often found associated with Maurer´s clefts 
are the ~25 nm uncoated vesicles as well as the ~80-100 nm electron-dense vesicles. These may be 
involved in the transfer of virulence factors to the surface of the infected RBC (Hanssen et al. 2010). J-
dots are membranous, highly mobile, parasite induced structures >30 nm in size within the host cell 
cytosol. A characteristic feature of the J-dots is presence of chaperones and the virulence factor 
P. falciparum erythrocyte membrane protein 1 
(PfEMP1) (See below). Therefore they might be 
involved in infected red blood cell (iRBC) 
cytoadherence (See below) (Külzer et al. 2010; 
Zhang et al. 2017). Similar, but distinct 
structures called K-dots are characterized by 
the presence of a parasite FIKK-kinase, which 
is involved in host cell remodelling (Kats et al. 
2014).  
A further challenge faced by the developing parasite is to escape elimination by the immune system of 
the host. To this end, the parasite uses the newly installed trafficking pathways to induce changes in 
its host cell via exported proteins to facilitate its survival. Mature-stage P. falciparum infected iRBCs 
develop ~50-120 nm protrusions with a height of ~2-20 nm on the surface (Figure 6) (Gruenberg et al. 
1983; Miller 1972; Quadt et al. 2012). These knobs act as anchoring platforms for the presentation of 
the important virulence factor PfEMP1 which enables cytoadhesion to cells of the hosts vasculature as 
well as antigenic variation (Baruch et al. 1995; Smith et al. 1995; Su et al. 1995). While this 
cytoadhesion allows the parasites to avoid splenic passage which might cause their elimination it may 
Figure 5: Typical Maurer’s cleft observed via transmission 
electron microscopy of CS2 iRBCs. Scale bar = 0.5 µm 
(Modified from Maier et al 2007). 
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also induce severe complications for the hosts. Obstruction of microvascular blood flow can cause 
endothelial dysfunction leading to inflammation and endothelial barrier disruption (Figure 7). 
Sequestration of iRBCs in specific organs is associated with severe disease like cerebral and 
placental malaria (Dondorp et al. 2008; Miller et al. 2002, 2013).  
Furthermore, P. falciparum infection 
influences the mechanical properties of the 
infected erythrocytes. Infected RBC rigidity 
increases over the course of the P. 
falciparum life cycle, which is thought to 
support cytoadherence functions and impacts 
iRBC retention in the spleen. Earlier less rigid 
stages are still found in the bloodstream and 
can readily perfuse through the spleen, while 
later stages are more likely to be retained and 
destroyed. However these later stages are 
generally removed from circulation via 
cytoadherence (Deplaine et al. 2011; Maier et 
al. 2009). There are three known parameters 
which influence the deformability of an 
erythrocyte: cytoplasmic viscosity, cell 
geometry and the elasticity of the erythrocyte membrane plus the underlying cytoskeleton (Chasis & 
Mohandas 1986; Mohandas & Gallagher 2008). Propagation of P. falciparum within an erythrocyte 
causes indirect changes of iRBCs deformability through the volume and shape of the parasite itself as 
well as direct changes by a broad spectrum of exported proteins (Sanyal et al. 2012). To properly 
Figure 7: Post-mortem analysis if a Vietnamese patient who died of cerebral malaria displays sequestrated 
P. falciparum iRBCs in the microvasculature leading to clogging of the vessel. Arrow indicates a mature stage 
P. falciparum iRBC (Ho et al. 2014). 
Figure 6: Mature P. falciparum infected erythrocyte displays 
knobs on the iRBC surface which enable cytoadhesion to 
cells of the host’s vasculature (Chan et al. 2014). 
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understand P. falciparum induced host cell remodelling it is vital to understand the molecular players 
fielded by the parasite -the exported proteins- and how they are trafficked to their target location within 
the iRBC.  
1.5 P. falciparum protein trafficking 
P. falciparum drastically alters its host cell in order to survive via several hundreds of exported proteins 
(Deponte et al. 2012). These proteins must cross the confines of the parasitophorous vacuole to be 
trafficked to their final destinations like the RBC cytoskeleton, knobs, Maurer´s clefts or the RBC 
cytosol. Specific targeting of these proteins to the various compartments implies the presence of 
distinct trafficking signals embedded in the proteins (Figure 4) (Przyborski et al. 2016). Canonical 
protein secretion in other systems is governed by hydrophobic N-terminal signal peptides which are 
cleaved off by signal peptidases after co-translational entry into the ER (Blobel & Dobberstein 1975a, 
1975b). Interestingly, secreted parasite proteins generally feature recessed N-terminal hydrophobic 
sequences for targeting to the secretory pathway (Albano et al. 1999; Lingelbach 1993; Marti et al. 
2004; Wickham et al. 2001). However, recessed N-terminal signal sequences seem to be mostly 
present in soluble secreted proteins, while secreted transmembrane proteins feature canonical N-
terminal signal sequences (Deponte et al. 2012). The default target for secreted P. falciparum proteins 
is the lumen of the PV (Adisa et al. 2003; Waller et al. 2000). Trafficking beyond these confines 
requires additional signals. For the bulk of the exported proteins trafficking to the host cell is driven by 
a pentameric signal sequence downstream of the hydrophobic signal sequence referred to as 
Plasmodium export element (PEXEL) or host targeting (HT) sequence. It is essential for the export of 
PEXEL containing proteins and has the consensus sequence RXLXE/Q/D, but also features relaxed 
variants (RXLXXE and R/K/HXL/IXXE) (Boddey et al. 2013; Hiller et al. 2004; Marti et al. 2004; 
Przyborski et al. 2005; Schulze et al. 2015). Recognition of the first and third amino acid of the PEXEL 
sequence by the resident protease Plasmepsin V within the ER leads to PEXEL cleavage by 
Plasmepsin V. The resulting terminus x/E/Q/D is acetylated to give rise to the mature PEXEL N-
terminus (Boddey et al. 2009, 2010; Chang et al. 2008). Additionally cryptic signals within the 
downstream region of the PEXEL sequence seem to be important for protein export (Grüring et al. 
2012; Tarr et al. 2013). Eight % of the total P. falciparum proteome (~four hundred individual proteins) 
feature a PEXEL sequence (Boddey et al. 2013; Hiller et al. 2004; Marti et al. 2004; Sargeant et al. 
2006; Schulze et al. 2015). A smaller group among the exported proteins are the PNEPs (PEXEL-
negative exported proteins) which are exported into the host cell despite a lack of a PEXEL sequence. 
Generally these proteins rely on an internal hydrophobic region for entry into the secretory system 
(Haase et al. 2009; Spielmann & Gilberger 2010). The N-terminus of many PNEPs resembles the 
mature PEXEL-N-terminus, which might play a role in trafficking of these proteins to the host cell. 
Apart from this, PNEP trafficking seems very heterogeneous (Haase et al. 2009; Spielmann & 
Gilberger 2010). For instance trafficking of the PNEP ring exported protein 1 (REX1) is governed by a 
sequence downstream of the hydrophobic stretch. Similarly trafficking of skeleton binding protein 1 
(SBP1), Maurer´s clefts histidine rich protein 1 (MAHRP1) and ring exported protein 2 relies on the first 
thirty-five, fifty and amino acids of the N-terminus, but furthermore requires presence of a 
transmembrane domain. Moreover, sequences just upstream of the TM and of SBP1 and MAHRP1 
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are involved in trafficking of the proteins 
(Dixon et al. 2008; Haase et al. 2009; 
Saridaki et al. 2009; Spycher et al. 2006). 
Translocation of proteins into the host cell 
cytosol is achieved via a PVM spanning 
translocon termed Plasmodium 
transporter of exported proteins (PTEX), 
in a process dependent on protein 
unfolding (Ansorge et al. 1996; Gehde et 
al. 2009; de Koning-Ward et al. 2009). 
PTEX functionality is essential for parasite 
survival and required for trafficking of both 
PEXEL and PNEP proteins into the host 
cell (Beck et al. 2014; Charnaud et al. 
2018; Elsworth et al. 2014). The PTEX 
core components are exported protein 2 
(EXP2), Plasmodium transporter of exported proteins 150 (PTEX150) and heat shock protein 101 
(HSP101) (Figure 8). The funnel shaped pore through the PVM is formed by seven EXP2s. These 
make contact to a HSP101-hexamer via a protruding arm, thereby interlocking a PTEX150 heptamere. 
PTEX150 is thought to have a structural role, while HSP101 drives the translocation process by 
unfolding of the cargo protein and thredding it through the central pore which spans the whole PTEX 
complex (Ho et al. 2018). Further auxiliary components of PTEX are thioreductase 2, which might be 
involved in the reduction of disulphide bonds in cargo proteins, P. falciparum surface protein 113 
which might be important for PTEX localization and Plasmodium transporter of exported proteins 88 as 
well as parasitophorous vacuolar protein 1 (PV1) with unknown functions (de Koning-Ward et al. 2009; 
Nyalwidhe & Lingelbach 2006). Recently a new protein-interacting complex was found located in the 
lumen of the PV. It is comprised of PV1, parasitophorous vacuolar protein 2 and exported protein 3 
and may play a role in delivery of unfolded cargo to PTEX (Batinovic et al. 2017).  
 
1.6 The P. falciparum exportome 
Compared to other Plasmodium species the exported proteins of P. falciparum -the “exportome”- is 
five to ten times larger, which is thought to play a part in its increased virulence compared to other 
species. Expansion of gene families containing heat shock protein 40 (HSP40) and Plasmodium 
helical interspersed subtelomeric (PHIST) domains are partly responsible for this expansion, possibly 
to aid in PfEMP1 export (Marti et al. 2005; Sargeant et al. 2006; Walsh et al. 2004). PfEMP1 is 
trafficked to and incorporated into the knobs, which serve as platforms for its presentation (Baruch et 
al. 1995; Smith et al. 1995; Su et al. 1995). The main components of the knobs are the parasite 
proteins knob associated histidine rich protein (KAHRP) and P. falciparum erythrocyte membrane 
protein 3 (PfEMP3) (Haldar & Mohandas 2007). Trafficking of PfEMP1 is a multistep process mediated 
Figure 8: Structure of the core PTEX complex. EXP2 forms a 
pore in the PVM and makes contact to HSP101 via a protruding 
arm, thereby interlocking PTEX150 (Ho et al. 2018). 
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by its C-terminal acidic terminal segment and transmembrane domains and additionally requires other 
parasite factors like REX1, MAHRP, SBP1 and several PfEMP1 transport proteins (Maier et al. 2008). 
Thus the parasite assigns a large part of its exportome to facilitate PfEMP1 functionality (Knuepfer et 
al. 2005; de Koning-Ward et al. 2016). In contrast to the invariant acidic terminal segment and 
transmembrane domains, the extracellular PfEMP1 domains are a hot spot of diversity and confer 
adhesion to various host cell receptors like chondroitin sulphate A (CSA), CD36, ICAM1 or EPCR 
(Flick & Chen 2004; Smith et al. 2013). Infected RBCs might sequester in different tissues depending 
on the bound host cell receptor. This can drastically affect disease outcomes (Miller et al. 2002). 
PfEMP1 is encoded by VAR genes that can be classified into three groups (A, B, C) according to their 
chromosomal localization and upstream sequence (Lavstsen et al. 2003). A typical P. falciparum 
parasite harbours ~60 var genes, but only expresses one of these dominantly while the others are 
silenced. Subsequent stochastic switching during the erythrocytic cycles allows antigenic variation as 
well as change of adhesive capabilities for the parasites (Chen et al. 1998; Gardner et al. 2002; Scherf 
et al. 1998). Other P. falciparum variant surface antigens aside from PfEMP1 are subtelomeric variant 
open reading frame (STEVOR) and repetitive interspersed family (RIFIN) families, with ~30 and ~150- 
200 members per parasite genome, respectively (Cheng et al. 1998). The functionality of most 
STEVOR and RIFINs is still unclear, but some RIFIN members are involved in immunevasion, while 
STEVORs have been associated with iRBC deformability (Goel et al. 2015; Saito et al. 2017; Sanyal 
et al. 2012). All three variant surface antigens play a part in a process called rosetting (Ghumra et al. 
2012; Goel et al. 2015; Niang et al. 2014). This involves the clumping of infected and non-infected 
RBCs and has been associated with disease severity (Carlson et al. 1990).  
Interestingly, the parasite also devotes ~2% of its genome to molecular chaperones and stress 
proteins like heat shock protein 40 (HSP40), HSP60, HSP70, HSP90 and HSP110 (Acharya et al. 
2007). Particularly HSP70 chaperones are known for their critical role in the folding, stabilization, 
refolding, degradation and translocation across membranes of proteins as well as assembly and 
disassembly of molecular complexes (Lemmon 2001; Shonhai 2010). As parasites need to withstand 
the febrile episodes they elicit in their hosts these stress proteins probably play a central role in P. 
falciparum survival. Of the six P. falciparum HSP70s five are located within the confines of the parasite 
which implicates them in P. falciparum proteome homeostasis. Notably, P. falciparum heat shock 
protein 70-x (PfHSP70x) instead localizes to the PV as well as J-dots which implicates this HSP70 in 
protein transport processes (Przyborski et al. 2015). Indeed PfHSP70x was shown to be involved in 
virulence associated functionalities of P. falciparum (Charnaud et al. 2017; Cobb et al. 2017). The 
parasite makes use of an extended HSP40 complement of forty nine to diversify the activity of its 
relatively few HSP70 chaperones. A considerable number of these HSP40 (~twenty three) are 
predicted to be exported implicating their function in host cell remodelling and virulence associated 
functionalities, likely through interaction with PfHSP70x or residual human HSP70 within the host cell 
(Botha et al. 2007; Hatherley et al. 2014; Sargeant et al. 2006). Proteins of the PHIST family localize 
within the infected red blood cell and are involved in PfEMP1 presentation, deformability as well as 
gametogenesis (Warncke et al. 2016). In a medium through-put deletion study Maier et al. found that 
~24% of genes encoding exported proteins could not be deleted and therefore may be essential for in 
vitro growth of the parasite. Deletion of ~40% these genes encoding proteins impacted on virulence 
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associated iRBC changes like rigidity, knobs and presentation of virulence factors (Maier et al. 2008). 
This puts exported proteins at the centre of P. falciparum virulence and highlights the need to 
understand their functionality in the fight against malaria. However, analysis of essential genes 
involved in these processes requires the use of genetic systems for conditional downregulation and 
deletion. 
1.7 Genetic systems to study essential P. falciparum genes 
With the first transient transfection of P. falciparum established in 1993 and the first successful gene 
deletions in 1997 genetic manipulation of these parasites has a surprisingly long history (Crabb et al. 
1997; Goonewardene et al. 1993; Ménard et al. 1997). In 2002 the first draft of the P. falciparum whole 
genome was released and opened up for investigation (Gardner et al. 2002). Despite this analysis of 
essential genes was infeasible due to the lack of conditional knockout or knockdown systems for 
several years to come, until recently when several new exiting technologies have been introduced (de 
Koning-Ward et al. 2015). This could for the first time enable identification and analysis of potentially 
druggable weak points in the arsenal of P. falciparum exported proteins. As each genetic systems 
features its own inherent advantages and disadvantages, choosing a system for routine investigation 
of essential genes is no straightforward process. 
Conditional knockouts can be achieved via the dimerizable cyclization recombinase (DiCre) system by 
modification of the gene of interest with 5´ and 3´ sequences for recognition by a recombinase. 
Conditional activity of a recombinase coupled either with a stage specific promoter or via ligand-based 
activation enables reliable excision of a gene of interest (GOI) (Collins et al. 2013; Combe et al. 2009). 
Alternatively conditional downregulation systems like the tet repressor and activating domain 
sequence (TRAD), destabilization domain (DD) or glucosamine-6-phosphate ribozyme (glmS) based 
systems can be used. Binding of the TRAD repressor to TetO binding sites integrated in the promoter 
Figure 9: Integration of a glmS sequence in the 3´ region of a gene of interest lead to expression of a chimeric 
messenger RNA featuring the active ribozyme. Upon addition of GlcN glmS cleaves itself thereby exposing free 
5´and 3´ RNA strands which are quickly degraded causing knock-down of gene expression.  
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of the gene of interest upon addition of anhydrotetracycline leads to a knockdown of gene expression. 
While this system works well in P. berghei it is impracticable for the use in P. falciparum as it requires 
modification of the gene of interest via double crossover homologous recombination (Duraisingh et al. 
2002; Pino et al. 2012). Also this system does not allow thigh regulation of protein levels (personal 
communication: PD. Dr. Jude Przyborski).  
The DD-system relies on the introduction of destabilizing domains, which enable control of protein 
stability via the Shld1 ligand. However, downregulation achieved via this system seems to be not very 
effective and sometimes even non- functional (Armstrong & Goldberg 2007, personal communication: 
PD. Dr. Jude Przyborski).  
The glmS system (Figure 9) makes use of a ribozyme from Gram
+
 bacteria to enable 
posttranscriptional downregulation of a gene of interest. The glmS sequence is integrated 3´ of the 
gene of interest causing the expression of chimeric messenger RNA (Prommana et al. 2013; Winkler 
et al. 2004). Addition of glucosamine (GlcN) causes the ribozyme to cleave itself leading to two 
products with exposed 5´ or 3´ ends. This might result directly from binding of GlcN to the ribozyme or 
alternatively through phosphorylation of GlcN to glucosamine-phosphate (GlcNP) which then activates 
the ribozyme (Watson & Fedor 2011). The 5´ product is then degraded by multiprotein RNA 
degradation complexes called exosomes, while the 3´ end is degraded by 3´-5´ exonucleases of the 
Xrn family (Meaux & Van Hoof 2006). The glmS system was successfully used by Elsworth et al. to 
investigate the essential genes HSP101 and PTEX150 (Elsworth et al. 2014). The glmS ribozyme 
shows low activity without GlcN addition, so little background activity can be expected (Winkler et al. 
2004). Another advantage of the glmS system is that possible effects of the downregulation of a gene 
would be “tuneable” via the GlcN concentration. 
Figure 10: Strategy for modification of P. falciparum genes with a GFP marker and a glmS sequence using SLI. 
Single crossover homologous recombination leads to integration of the plasmid into the genome and expression 
of a chimeric mRNA with two protein products: a target fused GFP and a BSD-resistance marker, separated by a 
SKIP peptide. Blasticidin treatment enables selection of integrant parasite lines. Errors in skipping potentially lead 
to a single, bigger fusion protein. 
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However, all these techniques require modification of the P. falciparum genome, which was commonly 
done via single crossover recombination and therefore very time-intensive. Recently the new 
technique selection-linked integration (SLI) was introduced which speeds up the process considerably 
through the use of two resistance markers. The first resistance marker (hDHFR) is used for a 
transgenic cell line carrying the plasmid, while the second resistance marker (BSD) is inserted behind 
the coding region of the GOI, enabling selection for integration events (Figure 10). The fusion protein 
as well as the second resistance marker are expressed as two separate proteins from a single 
transcript via a SKIP peptide (Birnbaum et al. 2017).  
 
1.8 Aim of this project 
The aim of this study was to use the new and promising glmS system to dissect the functionality of a 
set of sample-genes encoding exported proteins. Since P. falciparum exports hundreds of proteins into 
its host cell study of the entire exportome would be infeasible and was therefore restricted to a group 
of high priority targets. This also serves as an evaluation for the glmS system, to see if expansion of 
the system to analyse a larger set of genes would be feasible. Four genes were picked for analysis via 
the glmS system: PFA0660w, GEXP18, CBP1 and PfJ23. All of these genes have not previously been 
deleted and their expression profile as well as presence of a PEXEL sequence indicates that they 
encode exported proteins. 
PFA0660w (PF3D7_0113700) was previously targeted for deletion by Maier et al. Since this remained 
unsuccessful the gene was considered essential (Maier et al. 2008). PFA0660w encodes the protein 
PFA66 which is one of two type II HSP40 localized to mobile, parasite induced structures within the 
RBC cytosol in a cholesterol dependent manner (Külzer et al. 2010). HSP40s commonly interact with 
and regulate the activity of HSP70s. These are themselves involved in the folding, degradation, 
trafficking and assembly of proteins and protein complexes (Lemmon 2001; Shiber et al. 2014). 
Exported HSP40s like PFA66 could interact with residual human HSP70 and/or the exported 
plasmodial HSP70 PfHSP70x to facilitate these processes during P. falciparum protein export. 
According to in vitro data PFA66 stimulates the ATPase activity of PfHSP70x consistent with its 
function as a co-chaperone. Interestingly, PFA66 itself also exhibited substantial chaperone activity on 
its own (Daniyan et al. 2016). Recent in vitro data also indicate that PFA66 complexes together with 
PfHSP70x as well as PfEMP1. The presumed role of PFA66 in this complex is to act as both a 
chaperone and cholesterol binding protein via distinct binding sites, while PfHSP70x makes contact 
with PfEMP1 and PFA66 (Behl et al. 2019). As PfHSP70x supports virulence functionalities of 
P. falciparum involvement it would be reasonable to suspect involvement of PFA66 in similar 
processes (Charnaud et al. 2017; Cobb et al. 2017).  
GEXP18 (PFD0115c or PF3D7_0402400) was first identified as a putatively exported protein of the 
early gametocyte proteome but is also present during the asexual cycle were it localizes to the J-dots 
and possibly interacts with PfHSP70x (Silvestrini et al. 2010; Zhang et al. 2017).  
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The same proteome study by Silvestrini et al. first identified GEXP10. GEXP10 is also now known as 
CBP1 (PF3D7_0113900) which together with CBP2 localizes to the iRBC surface. Both proteins 
enable PfEMP1 independent cytoadherence of iRBCs to the adhesive chemokine CX3CL1 (Hermand 
et al. 2016; Silvestrini et al. 2010).  
PfJ23 (PF3D7_1001900)  was first identified as the product of hyp16, a conserved gene between 
rodent infecting Plasmodia as well as P. vivax and P. falciparum (Sargeant et al. 2006).  It was later 
localized to the Maurer’s clefts (Vincensini et al. 2005). In vitro data suggest interaction of PfJ23 with 
the ATS of PFEMP1 as well as SBP1 and it might therefore play a role in the trafficking of PNEP 
proteins like PfEMP1 and SBP1 (Kaur et al. 2018). 
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2 Results 
2.1 Modification of genomic PFA0660w, GEXP18, PfJ23 and CBP1 with glmS 
GlucN dependent downregulation of a gene via the glmS system requires modification of the genomic 
locus with a glmS sequence (Winkler et al. 2004). For regulation of PFA0660w, GEXP18, PfJ23 as 
well as CBP1 the glmS sequence was inserted outside of the coding region 3´ of the respective genes. 
Additionally control cell lines were generated where glmS had been replaced by an inactive version 
referred to as M9 (Winkler et al. 2004). Integrant cell lines were further modified with a green 
fluorescent protein (GFP) marker inserted at the 3´ region of their respective genes for ease of 
experiments. PFA0660w modification was achieved via single-crossover homologous recombination 
between homology regions of the gene and a transfected plasmid (Figure 11). Parasites with the 
desired mutation were enriched via drug-cycling (See: 4.1.20) and isolated from the non-integrant 
population via limiting dilution (See: 4.1.22). Both glmS and M9 cell lines were obtained from Wiebke 
Fleck in the second drug cycle and treated accordingly (M. Sc. thesis Wiebke Fleck). The resulting cell 
lines will be described as CS2PFA66
glmS
 and CS2PFA66
M9
 with indication of the respective clone. 
Modification of GEXP18, PfJ23 and CBP1 was carried out using a new method for modification of the 
P. falciparum genome: SLI (Figure 10). SLI involves the use of two resistance markers. The first one, 
human dihydrofolate reductase (hDHFR), was used for generation of a transfectants cell line carrying 
a plasmid with homology regions for integration of the episome into the desired gene locus. 
Expression of the second resistance marker (Blasticidin-S-deaminase, BSD) conferred resistance to 
Blasticidin and was coupled to integration of the plasmid into the genome (Birnbaum et al. 2017). 
Transfectant cell lines carrying the correct plasmid were obtained from Jessica Kimmel (B. Sc. thesis 
Jessica Kimmel) and yielded the cell lines CS2G18
glmS
 and CS2G18
M9
, CS2J23
glmS
 as well as 
CS2CBP
glmS
 and CS2CBP
M9
 after Blasticidin treatment. The cell line CS2J23
M9
 was generated by 
transfection of the plasmid PfJ23
glmS
 and blasticidin treatment of the re- grown parasites. In the next 
step correct modification of the genomic loci in all cell lines was analysed via integration PCR.  
Figure 11: Strategy for modification of the genomic PFA0660w locus in P. falciparum CS2 parasites with a glmS 
sequence and a GFP marker via single-crossover homologous recombination and drug cycling. 
Results 
17 
 
2.2 Verification of integration cell lines via integration PCR  
Correct integration of the plasmids into the P. falciparum genome was investigated via integration 
polymerase chain reaction (PCR, See: 4.1.4) using genomic DNA (gDNA) extracts (See: 4.1.1) from 
the cell lines. In this method four PCR-primers are used to yield specific bands upon correct 
integration of the plasmid into the genome (Figure 12). A forward- primer annealing just before the 
gene of interest (GOI)-targeting region on the plasmid (NotI-70_F) and a reverse primer annealing in 
the GFP-region (GFP_54_R) were used together to detect remnant, non-integrated plasmid. Usage of 
a forward primer annealing in the 5´ untranslated region (UTR) of the GOI and a reverse primer 
annealing in the 3´ UTR of the GOI allowed amplification of the wild-type locus. Upon integration of the 
plasmid into the genome these primers would not yield a product, since it would be too large to allow 
amplification (~12 kbp). Amplification across the recombination site by the 5´ UTR forward and GFP 
reverse primers or NotI-70_F forward and 3´ UTR reverse would result in a product and verify 
integration of the plasmid into the genome. Furthermore control PCRs were performed to amplify part 
of a plasmodial HSP70 or SBP1 gene as a positive control for gDNA-integrity and also to verify 
presence of KAHRP. Prolonged cell culture of P. falciparum is known to permit deletion of the 
subtelomeric arm of chromosome 2. Among the deleted genes is also the major knob component 
KAHRP which may results in a “knobless” phenotype (Culvenor et al. 1987; Pasloske et al. 1993; 
Pologe & Ravetch 1986). Detection of KAHRP demonstrates that potential knob-defects of the 
transgenic cell lines are not due to stochastic loss of KAHRP. 
 
 
Figure 12: Discrimination of plasmid, wildtype and modified samples via integration PCR. Integration events can 
be detected through usage of primers crossing the 5´ or 3´ junction of plasmid and genome generated during 
homologous recombination.  
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2.2.1 Verification of PFA0660w modification by integration PCR 
Integration PCRs were performed using ~200 ng gDNA- extracts from the CS2PFA66
glmS
 clones E11 
and G4 and CS2PFA66
M9
 clones C4 and D12. CS2 gDNA as well as ~1 ng of plasmid DNA were used 
as controls. Samples were size-separated on 1% agarose gels (See: 4.1.3) and the resulting bands 
were compared to the expected band sizes (Table 1). If further verification was needed DNA 
fragments were purified from the PCR reactions (See: 4.1.1) and digested with restriction enzymes 
(See: 4.1.5). Amplification of SBP1 as a positive control produced strong bands which imply integrity of 
the gDNA extracts (Figure 13). KAHRP primers produced a strong band at appropriate size from 
gDNA extracts of the cell lines CS2, CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4. In the same PCRs 
plasmid samples also produced weaker bands of larger size. 5´ Integration PCR showed products of 
1900 bp, 1700 bp, 1000 bp and 700 bp sizes in the clonal cell lines but in none of the controls. To 
investigate if the 1900 bp represents the 5´ integration band restriction digests were performed using 
the restriction enzymes AvrII, XhoI and NheI. Cleavage of the band by all three enzymes into the 
expected products suggested correct integration of the plasmids into the P. falciparum genome (Figure 
14). Amplification of the wild-type PFA0660w locus using the primers PFA0660w_5´_F and 
Figure 13: Integration-PCR verified successful 
modification of the PFA0660w locus in the single 
clones CS2PFA66
glmS
 E11 and G4 and 
CS2PFA66
M9
 clones C4 and D12. Specific 
primer pairs yielded bands representing SBP1 
and KAHRP. 5´ Integration PCR displayed 
multiple bands in all clones but none in the 
negative controls. 
Results 
19 
 
PFA0660w_3´_R was not successful likely due to the large size (>2 kbp) of the resulting product. 
Likewise 3´ Integration PCR using the primers Not-70_F and PFA0660w_3´_R did not yield a product 
(data not shown). The clones CS2PFA66
glmS
 clones E11 and G4 and CS2PFA66
M9
 clones C4 and D12 
display correct modification of PFA0660w and can be used for further experiments.  
 
Table 1: Expected band sizes in PFA0660w integration PCR and restrictive digest. 
PFA0660w 5´Integration 
Amplification control 
(SBP1) 
KAHRP 
Primers 
PFA0660w_5´_F 
GFP_54_R 
SBP1_F 
SBP1_R 
KAHRP_F 
KAHRP_R 
Expected Bands 1890 bp 1000 bp 550 bp 
Enzymes  
 
 
Expected Bands 
(AvrII) 
1800 bp 
100 bp 
 
Expected Bands 
(XhoI) 
1500  bp 
350 bp 
 
 
Expected Bands 
(NheI) 
1200 bp 
700 bp 
 
* * 
* 
* 
* * 
* 
* 
* * 
* 
* 
* * * 
* 
* 
* 
* * 
* 
Figure 14: Verification of the 5´ integration bands obtained in integration 
PCR from CS2PFA66
glmS
 clones E11 and G4 and CS2PFA66
M9
 clones 
C4 and D12 via restriction digest using AvrII, XhoI and NheI. The 1900 bp 
5´ integration band and its digested products are indicated by asterisk (*). 
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2.2.2 Verification of GEXP18 modification through integration PCR 
Following generation of the cell lines CS2G18
glmS
 and CS2G18
M9
 via SLI, modification of the GEXP18 
locus was investigated using integration PCR. Integration PCRs (See: 4.1.4) were performed using 
~200 ng of gDNA extracts (See: 4.1.1) from the parasites alongside ~1 ng plasmid (GEXP18
glmS
) and 
double-distilled H2O (ddH2O) controls. These were size-separated on 1% agarose gels (See: 4.1.3) 
and the resulting bands were compared to the expected band sizes (Table 2). Restriction digests 
(See: 4.1.5) were performed if further verification was needed. The HSP70 gDNA positive control 
yielded bands of expected size demonstrating gDNA integrity of all gDNA samples (Figure 15). All 
parasites lines including integrant cell lines also showed bands demonstrating presence of the wild-
type GEXP18 locus. Identity of the wild-type locus was also verified by EcoRI digest (Figure 16). All 
integrant cell lines also demonstrated presence of non-integrated plasmid. However these PCRs also 
show contamination in the CS2 and ddH2O control with plasmid DNA. 5´ and 3´ integration PCR 
displayed weak bands of the expected size, which were digested specifically by their respective 
restriction enzymes demonstrating integration of the plasmid into to the GEXP18 locus. Interestingly 
CS2G18
glmS
 and CS2G18
M9
 cell lines were found to have both the wild-type as well as modified 
GEXP18 locus. Since this could be indicative of a mixed population clonal lines originating from a 
single P. falciparum parasite were generated via limiting dilution.  
2.2.2.1 Investigation of CS2G18
glmS
 and CS2G18
M9
 clonal cell lines  
CS2G18
glmS
 and CS2G18
M9
 clonal cell lines were generated via limiting dilution (See: 4.1.22) and 
investigated via integration PCR and restriction digest as described above. Clonal dilutions were 
executed twice leading to a total of eight CS2G18
glmS
 and ten CS2G18
M9
 clones. HSP70 amplification 
controls demonstrated integrity of all gDNA samples. Almost all clonal cell lines showed bands 
representing the wild-type locus, integration of the plasmid as well as episomal plasmid (Figure 17, 
Figure 19, Figure 20), with the notable exceptions of CS2G18
M9
 F1 (Figure 17) not showing integration 
and CS2G18
glmS
 C1 (Figure 19) not showing plasmid bands. Wild-type, 5´ and 3´ integration bands 
were verified via restriction digest (Figure 18, Figure 21). Since all clones retained the wild-type 
GEXP18 locus none of the cell lines could be used for further experiments as the remaining wild-type 
gene might compensate any possible effect induced by a downregulation of GEXP18 via GlcN 
induced glmS cleavage (See: 3.1 for discussion). 
Table 2: Expected band sizes in GEXP18 integration PCRs and restriction digests. 
GEXP18 5´Integration 3´Integration Wild-type Plasmid 
Amplification 
Control  
Primers 
GEXP18_5´F 
GFP_54_R 
Not-70_F 
GEXP18_3´_F 
GEXP18_5´F 
GEXP18_3´_F 
Not-70_F 
GFP_54_R 
H70_F 
H70_R 
Expected Bands 1300 bp 1000 bp 1200 bp 1000 bp 470 bp 
Enzymes XhoI NotI EcoRI   
Expected Bands 
1220 bp 
80 bp 
920 bp 
80 bp 
1000 bp 
240 bp 
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Figure 15: Investigation of GEXP18 modification by integration PCR. 5´ and 3´ integration bands demonstrated 
modification of the GEXP18 locus in both cell lines CS2G18
glmS
 and CS2G18
M9
. Both cell lines also showed 
bands representing the wild-type and modified GEXP18 locus. 
Figure 16: Verification of GEXP18 integration PCR bands via restriction digest.  
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Figure 17: Clonal GEXP18 cell lines were obtained via limiting dilution and investigated via integration PCR. 
CS2G18
glmS
 C1 and G5 as well as CS2G18
M9
 E1-G10 clonal cell lines all retained the wild-type GEXP18 locus. 
All except CS2G18
M9
 F1 also feature modified GEXP18. 
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Figure 18: Verification of wild-type GEXP18, 5´ and 3 ´integration PCR bands via restriction digest. Bands are 
derived from the CS2G18
glmS
 C1 and G5 as well as CS2G18
M9
 E1-G10 clones. 
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Figure 19: Clonal GEXP18 cell lines were obtained via limiting dilution and investigated via integration PCR. All 
clonal CS2G18
glmS
 B11-F3 cell lines retained the wild-type GEXP18 and also displayed the modified GEXP18 
locus. 
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Figure 20: Clonal GEXP18 cell lines were obtained via limiting dilution and investigated via integration PCR. All 
clonal CS2G18
M9
 A4-H6 cell lines retained the wild-type GEXP18 locus and demonstrated modification of 
GEXP18. 
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Figure 21: Verification of 5´ GEXP18 integration PCR bands via restriction digest. Bands are derived from the 
CS2G18
glmS
 B11-F3 and CS2G18
M9
 A4-H6 5clones.  
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2.2.3 Verification of CBP1 Modification by integration PCR 
After generation of the cell lines CS2CBP
glmS
 and CS2CBP
M9
 via SLI integration parasite cell lines 
were verified via integration PCR and restriction digest (Described above, see: 2.2.2). Amplification 
controls of all gDNA samples demonstrated gDNA integrity (Figure 22, Table 3). GlmS and M9 cell 
lines cell lines showed 5´ as well as 3´ integration bands and no remnants of neither plasmid DNA nor 
wild-type locus were detected. Successful amplification of KAHRP indicated chromosomal integrity. 
Furthermore 5´ and 3´ integration as well as wild-type bands were verified by restriction digest (Figure 
23). The CS2CBP
glmS
 and CS2CBP
M9
 demonstrate successful modification of the CBP1 locus and can 
be used for further experiments. 
 
Table 3: Expected band sizes for CBP1 integration PCR and restriction digest. 
CBP1 5´Integration 3´Integration Wild-type locus Plasmid 
Primers 
CBP1_5´_F 
GFP_54_R 
NotI-70_F 
CBP1_3´_R 
CBP1_5´_F 
CBP1_3´_R 
Not-70_F 
GFP_54_R 
Expected Band 1000 1380 1350 1100 
Restriction digests XhoI NotI EcoRI  
Expected Bands 
920 bp 
80 bp 
1300 bp 
80 bp 
900 bp 
440 bp 
 
Controls 
Amplification 
Control 
KAHRP   
Primers 
H70_F 
H70_R 
KAHRP_F 
KAHRP_R 
  
Expected Bands 550 bp 470 bp   
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Figure 22: 5´ and 3´ integration-PCR verified successful modification of the CBP1 locus in the cell lines 
CS2CBP
glmS
 and CS2CBP
M9
.  
Figure 23: Verification of CBP1 integration PCR bands via restriction digest. 
Results 
29 
 
2.2.4 Verification of PfJ23 modification using integration PCR 
The cell lines CS2J23
glmS
 and CS2J23
M9
 were generated via SLI and investigated via integration PCR 
and restriction digest (Described above, see: 2.2.2). The amplification control yielded bands of 
expected size demonstrating gDNA integrity of all gDNA samples (Figure 24, Table 4). Integrant cell 
lines showed both 5´ and 3´integration. Furthermore neither remnant plasmid nor wild-type locus were 
detected and amplification of KAHRP demonstrates stability of chromosome two. DNA bands obtained 
by 5´ and 3´ integration as well as wild-type PCR were readily verified via restriction digest (Figure 25), 
demonstrating that the cell lines carry the desired mutation and can be used for further experiments. 
 
Table 4: Expected band sizes for PfJ23 integration PCR and restriction digest. 
PfJ23 5´Integration 3´Integration Wild-type locus Plasmid 
Primers 
PfJ23_5´_F 
GFP_54_R 
Not-70_F 
Pf23_3´_R 
PfJ23_5´_F 
Pf23_3´_R 
Not-70_F 
GFP_54_R 
Expected Bands 1100 1100 1050 1100 
Enzymes XhoI NotI EcoRI  
Expected Bands 
1020 bp 
80 bp 
1020 bp 
80 bp 
600 bp 
450 bp 
 
Controls KAHRP 
Amplification 
Control 
  
Primers 
KAHRP_F 
KAHRP_R 
H70_F 
H70_R 
  
Expected Bands 550 bp 470 bp   
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Figure 24: 5´ and 3´ integration-PCR verified successful modification of the PfJ23 locus in the cell lines 
CS2J23
glmS
 and CS2J23
M9
 cell lines. 
Figure 25: Verification of PfJ23 Integration PCR bands via restriction digest 
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2.3 Investigation of fusion protein export by immunofluorescence assay 
Fusion protein export was analysed in the remaining, successfully modified strains CS2PFA66
glmS
 E11 
and CS2PFA66
M9
 C4, CS2J23
glmS
 and CS2J23
M9
 as well as CS2CBP
glmS
 and CS2CBP
M9
 by 
immunofluorescence assay (IFA, See: 4.1.28) alongside the parental strain CS2. Following cultivation 
of the parasites to a parasitemia of ~2% trophozoites ~3x10
7
 cells were spread on a microscopy slide 
and fixed with acetone-methanol. An α-GFP (chicken) primary antibody was used for detection of the 
fusion-proteins via an α-chicken-Cy2 secondary antibody. Also DAPI was used to stain parasite nuclei. 
The fluorescent background was assessed in controls without primary antibody and found to be 
negligible for all strains (not shown). CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4 as well as CS2J23
M9
 
produced a staining limited to the parasite cytosol which was indistinguishable from labelling of non-
GFP expressing CS2 (Figure 26, Figure 27). CS2J23
glmS
, CS2CBP
glmS
 and CS2CBP
M9
 showed 
labelling in punctuated structures within the infected erythrocyte (See: 3.2 for discussion). 
Figure 26: Investigation of PFA66-GFP and CBP1-GFP fusion protein export via IFA using α-GFP (chicken) 
primary and α-chicken- Cy2 secondary antibodies. Nuclei were stained with 1 ng/ml DAPI. Labelling of 
CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4 was indistinguishable from labelling of the parental CS2. CS2CBP
glmS
 
and CS2CBP
M9
 presented punctuated structures within the RBC cytosol. Channel intensities were adjusted for 
overlays via thresholding in ImageJ to improve visibility. Microscopy settings: DAPI 60 ms, αGFP 350 ms. 
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2.4 Downregulation of fusion proteins via glmS 
In the following experiments GlcN dependent downregulation of fusion protein abundance was 
investigated using the three remaining glmS strains CS2PFA66
glmS
 E11, CS2J23
glmS
 and CS2CBP
glmS
 
alongside their M9 controls. Possible effects of this downregulation on parasites viability and 
morphology were analysed for all three genes. Influences of PFA0660w downregulation on host cell 
modifications were analysed in more detail. 
2.4.1 Investigation of PFA0660w downregulation 
To investigate if integration of glmS enabled GlcN induced downregulation of PFA0660w, fusion 
protein abundance in protein extracts derived from GlcN treated and non-treated parasite cultures 
were investigated via Western-blot. Trophozoite cultures of the CS2PFA66
glmS
 E11, CS2PFA66
M9
 C4 
cell lines as well as the parental strain CS2 were split into two cultures with a final parasitemia of 1% 
(Figure 28). Then one culture was treated with 1 mM GlcN (f.c.) and the other was treated with the 
solvent ddH2O. After incubation for 48 hours (h) parasites were purified via magnetic cell sorting 
(See: 4.1.24). Then protein extracts were prepared followed by size-separation on a polyacrylamide 
gel (See: 4.1.11). Fusion protein abundance was visualized via Western-and immuno-blotting 
Figure 28: Work-flow of a glmS-regulation experiment. Two ~1% trophozoite cultures were treated with GlcN or 
ddH2O, respectively. Parasites were harvested in the next cycle via magnetic cell sorting, then protein extracts 
were prepared and analysed via Western-and immuno-blotting.  
Figure 27: Investigation of PfJ23-GFP fusion protein localization via IFA using α-GFP (chicken) primary and α-
chicken- Cy2 secondary antibodies. Nuclei were stained with 1 ng/ml DAPI. Labelling of CS2J23
M9
 was 
indistinguishable from labelling of the parental CS2. CS2J23
glmS
 displayed punctuated structures within the RBC 
cytosol. Channel intensities were adjusted for overlays via thresholding in ImageJ to improve visibility. Microscopy 
settings: DAPI 60 ms, αGFP 350 ms. 
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(See: 4.1.12) using antisera raised against GFP (mouse) primary and α-mouse-HRP secondary 
antibodies. Total protein abundance in the samples was assessed using three control primary 
antibodies: α-serine-rich (SERP) (rabbit), α-glycophorin A+B (GLYCO) (mouse), α- exported antigen 1 
(EXP1) rabbit-HRP. SERP and EXP1 antisera targeted parasite proteins, while the GLYCO antiserum 
targeted the host cell proteins glycophorin A and B. α-GFP Western blots yielded a band from the 
PFA0660w cell lines at ~65 kDa, which likely represents the PEXEL cleaved fusion protein (Figure 
A) 
Figure 29: A) Exemplary Western blot generated in the glmS regulation experiments. Protein extracts from CS2, 
glmS and M9 trophozoites incubated with 1 mM GlcN f.c. or ddH2O for 48 h were investigated by immunoblot. 
The amount of protein applied to each lane is equivalent to 1x10
7
 parasites. The parasite proteins SERP and 
EXP1 as well as the host cell protein GLYCO were used as loading control, while fusion proteins were detected 
with an α-GFP antibody. B) Dot blot showed downregulation of fusion protein abundance from ~25% to ~2.5% in 
the glmS cell line upon addition of GlcN. Also fusion protein abundance was lower in the non-treated glmS 
(~25%) cell line compared to the non-treated M9 (~80%) cell line. Shown: Mean, Standard-deviation (SD); 
Statistical analysis via two-tailed t-test. p > 0,05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
B) 
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29A). No GFP band was detected in the parental strain CS2. SERP and GLYCO Western-blots 
displayed bands at 130 kDa, 44 kDa and 37 kDa respectively which coincides with the expected 
molecular weights for these proteins (Figure 29A). For EXP1 bands at ~20 kDa were detected 
indicating that the protein migrates slightly slower than expected. These experiments were done in 
triplicate. Then the intensity of the bands were measured via ImageJ and used to calculate 
GFP/SERP, GFP/GLYCO and GFP/EXP1 values for each blot. As seen in figure 28B GlcN treatment 
significantly downregulated expression of PFA0660w in the glmS cell line to ~10 % of the non-treated 
glmS control. In addition fusion protein abundance was significantly higher in the non-treated M9 
control than in the non-treated glmS cell line. Potential effects of PFA0660w regulation on parasite 
morphology and viability were investigated by giemsa stained smears (See: 2.4.1.1) and Plasmodium 
lactate dehydrogenase (pLDH) assay (See: 2.4.1.2). 
 
Table 5: Theoretical molecular weights expected in the PFA66, PfJ23 and CBP1 Western-blots. 
 
2.4.1.1 Parasite morphology upon PFA0660w downregulation 
To investigate parasite morphologies upon downregulation of PFA0660w cultures of the cell lines 
CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4 were treated with 1 mM GlcN (f.c.) or ddH2O alongside the 
parental strain CS2. Preparation of Giemsa-stained smears (See: 4.1.14) 0 h, 48 h and 96 h post 
treatment allowed investigation of parasite morphologies. Parasites cultures were prepared with 0.5% 
(48 h) or 0.1% (96 h) trophozoite parasitemia in order to avoid crashing of the culture. No striking 
differences were observed that would be bigger than the variation observed in the CS2 cell line at both 
time points (Figure 30). 
  
Fusion-proteins PFA66-GFP J23-GFP J23-GFP-BSD CBP-GFP CBP-GFP-BSD 
Theoretical MW 67 kDa 49 kDa 65 kDa 49 kDa 65 kDa 
Marker- proteins SERP GLYCO AB EXP1   
Theoretical MW 140 kDa 38, 46 kDa 15 kDa   
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Figure 30: Comparison of parasite morphologies of the parental strain CS2 with the two transgenic cell lines 
CS2PFA66
glmS
 E11 and CS2PFA66
M9 
C4 upon treatment with 1 mM GlcN for 0 h, 48 h and 96 h in Giemsa-
stained smears. 
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2.4.1.2  Parasite viability following PFA0660w downregulation 
To investigate potential growth defects upon downregulation of PFA0660w parasite growth was 
measured via an Plasmodium lactate dehydrogenase (pLDH) assay (See: 4.1.25) upon treatment of 
the strains CS2PFA66
glmS
 E11, CS2PFA66
M9
 C4 as well as the parental strain CS2 with 1 mM GlcN or 
ddH2O. The three strains were seeded at 0.1% (96 h experiment) or 0.5% (48 h experiment) 
trophozoite parasitemia to avoid crashing of the cultures. Samples were taken at 0 h and 48 h or 96 h 
post treatment. Then parasite growth was investigated by measuring the activity of the parasite 
enzyme LDH in a colorimetric reaction. The PFA0660w cell lines did not show any significant growth 
changes upon treatment with 1 mM or 2 mM GlcN for 48 h or with 1 mM GlcN for 96 h (Figure 31, 
 
Figure 31: Relative parasite growth upon treatment of the cell lines CS2, CS2PFA66
glmS
 E11 and 
CS2PFA66
M9 
C4 with A) 1 mM or B) 2 mM GlcN or ddH2O for 48 h. Shown: Mean, SD; Statistical 
analysis via two-tailed t-test. p > 0.05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
B) 
A) 
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Figure 32, See: 3.6 for discussion). Further experiments focussed on parasite induced changes of the 
infected RBC, since the potential interaction of PFA66 with PfHSP70x pointed towards an involvement 
of PFA66 in these processes (Charnaud et al. 2017). These are associated with P. falciparum 
pathology and involve the formation of knobs on the iRBC surface (See: 2.4.1.3), iRBC cytoadherence 
(See: 2.4.1.4.2) as well as iRBC rigidity changes (See: 2.4.1.5). 
 
2.4.1.3 Investigating iRBC morphology upon PFA0660w downregulation via scanning electron 
microscopy 
Infected RBC morphologies upon downregulation of PFA0660w were investigated via scanning 
electron microscopy (SEM, See: 4.1.31). The cell lines CS2, CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4 
were seeded at ~1% trophozoite parasitemia into two cultures each. Then one culture was treated with 
1 mM GlcN and the other one with ddH2O. Parasites were purified in the next cycle after 48 h using 
magnetic cell sorting (See: 4.1.24), fixed and dehydrated for SEM according to the Marburg protocol 
(See: 4.1.31). Examination of the resulting pictures displayed no major differences in knob 
morphologies and numbers upon downregulation of PFA0660w (Figure 33, Figure 34). 
 
Figure 32: Relative parasite growth upon treatment of the cell lines CS2, CS2PFA66
glmS
 E11 and 
CS2PFA66
M9 
C4 with 1 mM GlcN or ddH2O for 48 h. Shown: Mean, SD; Statistical analysis via two-tailed t-test. p 
> 0.05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
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Figure 33: Scanning electron microscopy allows investigation of knob-morphologies of the transgenic cell lines 
CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4 as well as the parental strain CS2 upon treatment with 1 mM GlcN (f.c.) 
for 48 hours imaged via SEM. Marked areas are enlarged in figure 33. 
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2.4.1.4 Analysis of iRBC cytoadherence using the CSA binding assay 
P. falciparum cytoadherence relies on the transport of the major virulence factor PfEMP1 to the 
surface of the infected erythrocyte, where it is incorporate into knobs. PfEMP1 leads to cytoadherence 
of iRBCs to cells of the host’s vasculature and can be investigated via a CSA binding assay (Baruch et 
al. 1995; Smith et al. 1995; Su et al. 1995, See: 4.1.27). In this assay CSA, a ligand to the PfEMP1 
variant VAR2CSA is spotted onto a petri dish (Beeson et al. 1998). Parasites are then allowed to 
cytoadhere to these spots and non-bound parasites are washed away while CSA-bound parasites 
remain and can be counted microscopically. Non CSA-coated, blocked spots were used as a negative 
control. Also CSA coated spots with addition of soluble CSA during the cytoadhesion phase were used 
to investigate if iRBC binding was specific. First experiments were done to establish (See: 2.4.1.4.1) 
the assay to allow investigation of CSA directed cytoadherence upon downregulation of PFA0660w 
(See: 2.4.1.4.2).  
 
Figure 34: Scanning electron microscopy shows close up of knob morphologies of the transgenic cell lines 
CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4 after 48 h incubation with 1 mM GlcN or ddH2O. Selected knob-
resembling structures are marked with arrows. Full-size pictures can be seen in figure 33. 
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2.4.1.4.1 Establishing experiments 
In an initial experiment the binding capacity to CSA of the strong CSA binding parasite line FCR3 was 
analysed and compared to non-infected RBCs (Figure 35). Binding of FCR3 (CSA) parasites to CSA 
was significantly higher than binding to phosphate buffered saline (PBS) coated, blocked spots. CSA 
binding was much lower upon addition of soluble CSA during cytoadhesion, which indicates that the 
binding was specific to CSA. Binding of RBCs to the spots was comparatively low without any 
significant differences. Similarly, when FCR3 parasites selected for binding of CSA or ICAM were used 
Figure 35: Cytoadhesion of A) FCR3(CSA) and B) non-infected RBCs to CSA. Blocked PBS-coated spots were 
used as negative controls. Also adhesion to CSA-coated spots upon addition of soluble CSA was investigated to 
ensure that binding was CSA specific. Shown: Mean, SD; Statistical analysis via two-tailed t-test. p > 0.05 = non-
significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
Figure 36:  Cytoadherence to CSA of the strain FCR3 selected for binding of the PfEMP1 ligand CSA (A) and 
ICAM (B). PBS-coated, blocked spots were used as negative controls. Also iRBC binding to CSA in the presence 
of soluble CSA was investigated to ensure CSA-specificity of iRBC binding. Shown: Mean, SD; Statistical analysis 
via two-tailed t-test. p > 0,05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
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FCR3(CSA) bound strongly and specifically to CSA, while FCR3(ICAM) showed negligible binding 
(Figure 36). This demonstrates that CSA binding and non-binding P. falciparum strains can be 
distinguished in this assay. The P. falciparum strain used for generation of the transgenic cell lines 
was CS2. Non CSA-binding selected CS2 bound only negligible to CSA when compared to 
FCR3(CSA) (Figure 37). Selection of CS2 for CSA binding via panning (See: 4.1.26) restored binding 
of the strains to CSA (Figure 38). Therefore panning of parasites was regularly executed to retain the 
CSA binding phenotype of the transgenic P. falciparum cell lines in further experiment. 
 
Figure 37: Cytoadherence of the P. falciparum strains (A) FCR3(CSA) and (B) non CSA binding-selected CS2 
parasites. Shown: Mean, SD; Statistical analysis via two-tailed t-test. p > 0.05 = non-significant (ns); *p < 0.05; **p 
< 0.01; ***p < 0.001 
Figure 38: CSA binding of the P. falciparum strains FCR3 (A) and CS2 (B) both selected for CSA binding. 
Shown: Mean, SD; Statistical analysis via two-tailed t-test. p > 0.05 = non-significant (ns); *p < 0.05; **p < 0.01; 
***p < 0.001 
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2.4.1.4.2 iRBC cytoadherence upon PFA0660w downregulation 
To investigate potenital changes in iRBC cytoadherence to CSA upon downregulation of PFA0660w 
the cell lines CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4 were split into two 1% trophozoite cultures. 
After incubation for 48 h with and without 1 mM GlcN or ddH2O iRBC cytoadherence was investigated 
via CSA binding assays (Figure 39). All experiments were done in 6 repetitions. No significant 
difference was observed in binding of CSA in the glmS and M9 cell lines upon treatment with GlcN.  
 
Figure 39: Investigation of cytoadherence to CSA upon GlcN and ddH2O treatment of the cell lines 
CS2PFA66
glmS
 E11 and CS2PFA66
M9
 C4. Shown: Mean, SD; Statistical analysis via two-tailed t-test. p > 0.05 = 
non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
A) CS2PFA66glmS E11 
B) CS2PFA66M9 C4 
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2.4.1.5 Using microsphiltration to investigate iRBC rigidity  
Infected RBC rigidity is central of P. falciparum pathology as it impacts the retention rate of the iRBCs 
in the human spleen. Rigidity increases during the P. falciparum lifecycle which means that earlier, 
less rigid stages can perfuse through the spleen while later more rigid stages are retained 
(Deplaine et al. 2011). IRBC rigidity can be investigated in an artificial spleen, where a layer of 
different-sized metal microbeads mimics the filtering action of the spleen. Since the rigidity of 
P. falciparum changes drastically during progression of the life cycle, stringent synchronization of the 
parasites is required (Deplaine et al. 2011). Artificial spleen assays were performed with trophozoite 
stage parasites at either 28-32 hours post invasion (hpi) during establishment of the assay 
(See: 2.4.1.5.1) or at 25-29 hpi to investigate potential changes in iRBC rigidity upon PFA0660w 
downregulation (See: 2.4.1.5.2). The time point for the PFA0660w experiment was chosen according 
to the stage of highest PFA0660w expression.  
 
2.4.1.5.1 Establishing experiments 
Artificial spleen experiments were established using 28-32 hpi CS2 trophozoites in triplicate 
(See: 4.1.29). Upstream, downstream and retained samples were collected. Parasitemias were 
determined via giemsa-stained smears (See: 4.1.14) counting 2000-5000 RBCs in total for each 
sample. A range of upstream parasitemias was used: 11%, 0.4% and 0.9%. The corresponding 
downstream parasitemias were 0.7%, 0.03% and 0.2% indicating filtration by the artificial spleen 
(Figure 40). The parasitemias in the retained fraction were elevated: 20%, 2% and 6%, indicating that 
the parasites were indeed retained in the artificial spleen. Calculated retention rates were 93%, 92% 
and 77% with and average retention rate of 87% (Figure 40D) which compared well to values in the 
literature for similar 34 hpi NF54 trophozoites: 83% and 87% (Sanyal et al. 2012).  
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Figure 40: Artificial spleen experiments with 28-34 hpi CS2 trophozoites. In the first experiment (A) filtering of an 
upstream parasitemia of 11% yielded a downstream parasitemia of 0.7% and a parasitemia in the retained of 
20%. The retained sample is only represented with one data-point because of a difference in data collection. The 
second experiment (B) showed an upstream parasitemia of 0.4%, downstream parasitemia of 0.03% and retained 
parasitemia of 2%. Similarly, the third experiment (C) had an upstream parasitemia of 0.9%, downstream 
parasitemia of 0.2% and retained parasitemia of 0.2%. The calculated retention rates (D) for these experiments 
were 93% (DI), 92% (DII) and 77% (DIII) with an average of 87%. This was in accordance with retention rates of 
83% and 87% for 34 hpi NF54 trophozoites from the literature. Shown: Mean, SD; Statistical analysis via two-
tailed t-test. p > 0.05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
A) B) 
C) D) 
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2.4.1.5.2 iRBC rigidity upon PFA0660w downregulation 
To investigate iRBC rigidity upon downregulation of PFA0660w the parasite cell lines CS2PFA66
glmS
 
E11 and CS2PFA66
M9
 C4 were tightly synchronized to a 25-29 hpi time point (See: 4.1.29). During 
seeding of the parasites for synchronization the cultures were split into two, one was treated with 
1 mM GlcN and the other one with ddH2O. In contrast to previous experiments parasitemias were 
determined using flow cytometry (See: 4.1.30) to reduce workload and increase sensitivity. 
Experiments were done in duplicates. Overall retention rates were at ~90-95% and too high for the 
used P. falciparum time point which precludes any worthwhile conclusions from these experiments 
(Figure 41). The reasons for this are unknown but might involve technical issues (See: 3.5 for 
discussion). 
 
2.4.2 Investigation of CBP1 downregulation 
Downregulation of CBP1 in the cell lines CS2CBP
glmS
 and CS2CBP
M9
 was investigated like described 
previously for PFA0660w (See: 2.4.1). CBP1 cell lines showed a band at ~53 likely representing the 
CBP fusion protein as well as a secondary band at ~60 kDa, which might constitute non-skipped 
fusion protein (Figure 42). The results show that GlcN treatment significantly downregulated 
expression of the CBP1 fusion protein in the glmS cell lines to ~5% of the non-treated glmS control. 
No such effect was found upon treatment of the M9 control with GlcN. In the following experiments 
parasite morphology (See: 2.4.1.1), viability (See: 2.4.1.2) and knob morphology (See: 2.4.1.3) was 
investigated upon downregulation of CBP1. 
  
Figure 41: Analysis of iRBC rigidity in artificial spleen experiments upon treatment of the strains CS2PFA66
glmS
 
E11 and CS2PFA66
M9
 C4 upon with GlcN and ddH2O. Parasitemias were determined using flow-cytometry. 
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2.4.2.1 Parasite morphology following CBP1 downregulation 
Parasite morphologies upon downregulation of CBP1 were investigated via Giemsa-stained smears of 
the cell lines CS2, CS2CBP
glmS
 and CS2CBP
M9
 as described before for PFA0660w (See: 2.4.1.1). No 
striking differences were observed upon incubation of all three cell lines with 1 mM GlcN or ddH2O for 
48 h and 96 h (Figure 43). 
Figure 42: A) Exemplary immunoblot obtained during a CBP1 regulation experiment. Protein extracts from CS2, 
CS2CBP
glmS
 and CS2CBP
M9
 trophozoites incubated with 1 mM GlcN (f.c.) or ddH2O for 48 h were applied to a 
polyacrylamide gel. The amount of protein applied to each lane is equivalent to 1x10
7
 parasites. The parasite 
proteins SERP and EXP1 as well as the host cell protein GLYCO were used as loading controls, while fusion 
proteins were detected with an α-GFP antibody. B) The CS2CBP
glmS
 cell line shows downregulation upon 
treatment with GlcN from ~50% to ~2,5%. Shown: Mean, SD; Statistical analysis via two-tailed t-test. p > 0.05 = 
non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
A) 
B) 
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Figure 43: Comparison of parasite morphologies of the parental strain CS2 with the two transgenic cell lines 
CS2CBP
glmS
 and CS2CBP
M9
 upon treatment with 1 mM GlcN or ddH2O for 0 h, 48 h and 96 h in Giemsa stained 
smears. 
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2.4.2.2  Parasite viability during CBP1 downregulation 
Parasite viability upon downregulation of CBP1 was investigated via a LDH assay as described 
previously for PFA0660w (See: 2.4.1.2). CS2CBP
glmS
 showed a small but significant growth advantage 
upon treatment with GlcN for 48 h, which was not replicated in the 96 h experiment (Figure 44). Also 
CS2 showed a slight growth advantage with GlcN for 96 h, but not in the 48 h experiment. Overall 
CBP1 downregulation did not cause a growth defect (See: 3.6 for discussion).  
 
 
Figure 44: Relative parasite growth upon treatment with 1 mM GlcN for 48 h (A) and 96 h (B) was measured via 
pLDH assay. None of the parasite lines CS2, CS2CBP
glmS 
and CS2CBP
M9 
show impaired growth. Shown: Mean, 
SD; Statistical analysis via two-tailed t-test. p > 0.05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
 
A) 
B) 
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2.4.2.3 Knob morphology upon CBP1 downregulation 
Infected RBC morphologies upon downregulation of CBP1 were investigated via SEM like described 
previously for PFA0660w using the cell lines CS2, CS2CBP
glmS
 and CS2CBP
M9
 according to the 
Heidelberg SEM protocol (See: 2.4.1.3). No major differences were observed neither in number nor 
morphology of the knob of all three strains upon downregulation of CBP1 (Figure 46, Figure 45, 
See: 3.6 for discussion). 
 
 
 
  
Figure 45: Close-up knob morphology upon CBP1 downregulation. Structures resembling knobs are marked with 
arrows.  
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Figure 46: Analysis of knob morphologies via scanning electron microscopy imaging of late-stage CS2, 
CS2CBP
glmS
 and CS2CBP
M9
 iRBCs upon treatment with 1 mM GlcN (f.c) for one cycle. Samples were prepared 
according to the Heidelberg SEM protocol. The marked areas are enlarged in figure 45.  
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2.4.3 Downregulation of PfJ23 via glmS 
Downregulation of PfJ23 in the cell lines CS2J23
glmS
 and CS2J23
M9
 was investigated like described 
previously for PFA0660w (See: 2.4.1). PfJ23 cell lines showed a band at ~55 kDa likely representing 
the PfJ23 fusion protein, as well as a secondary band at ~67 kDa, which might constitute non-skipped 
fusion protein (Figure 47). Interestingly, treatment of the CS2J23
M9
 cell line caused an upregulation of 
PfJ23 expression. Also the ddH2O treated glmS cell line displayed higher fusion protein abundance 
than the M9 control.  
B) 
Figure 47: A) Exemplary immunoblot obtained during the PfJ23 regulation experiments. Protein extracts from 
CS2, CS2J23
glmS
 and CS2J23
M9
 trophozoites incubated with 1 mM GlcN (f.c.) or ddH2O for 48 h were applied to a 
polyacrylamide. The amount of protein applied to each lane is equivalent to 1x10
7
 parasites. The parasite proteins 
SERP and EXP1 as well as the host cell protein GLYCO were used as loading controls, while fusion proteins 
were detected with an α-GFP antibody. B) Effect of GlcN-treatment on the relative fusion protein abundance in 
CS2J23
glmS
 and CS2J23
M9
 cell lines. The glmS cell line shows downregulation of fusion protein abundance upon 
GlcN- treatment from ~80% in the ddH2O control to ~20%. In the M9 control GlcN treatment caused an 
upregulation from ~40% to ~90%. Fusion protein abundance in the non-treated samples is higher in the glmS cell 
line (~70%) than in the M9 cell line (~40%). p > 0.05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
A) 
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2.4.3.1 Parasite morphology upon PfJ23 downregulation 
Parasite morphologies upon downregulation of PfJ23 were investigated via Giemsa-stained smears of 
the cell lines CS2, CS2J23
glmS
 and CS2J23
M9
 as described before for PFA0660w (See: 2.4.1.1). No 
major differences were observed upon incubation of all three cell lines with 1 mM GlcN or ddH2O for 
48 h and 96 h (Figure 48, Figure 49). 
 
 
 
  
Figure 48: Comparison of parasite morphologies of the parental strain CS2 with the two transgenic cell lines 
CS2J23
glmS
 and CS2J23
M9
 upon treatment with 1 mM GlcN or ddH2O for 0 h and 48 h in Giemsa stained smears. 
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Figure 49: Comparison of parasite morphologies of the parental strain CS2 with the two transgenic cell lines 
CS2J23
glmS
 and CS2J23
M9
 upon treatment with 1 mM GlcN or ddH2O for 96 h in Giemsa stained smears. 
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2.4.3.2 Parasite viability following PfJ23 downregulation 
Parasite viability upon downregulation of PfJ23 was investigated via a LDH assay as described above 
for PFA0660w (See: 2.4.1.2). CS2J23
M9
 presented a minor, but significant growth advantage upon the 
treatment with GlcN for 48 h which was not replicated in the 96 h experiment. Overall PfJ23 
downregulation did not cause a growth defect (Figure 50, See: 3.6 for discussion).  
 
 
  
Figure 50: Relative parasite growth upon treatment with 1 mM GlcN for A) 48 h and B) 96 h was measured via 
pLDH assay. None of the parasite lines CS2, CSJ23
glmS
 and CS2J23
M9
 display a growth defect. Shown: Mean, 
SD; Statistical analysis via two-tailed t-test. p > 0.05 = non-significant (ns); *p < 0.05; **p < 0.01; ***p < 0.001 
A) 
B) 
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2.5 Truncation of PFA0660w via SLI- TGD  
Downregulation of PFA0660w via glmS to ~10% did not affect parasite viability (See: 2.4.1). This was 
unexpected as previous studies suggested essentiality of PFA0660w (Maier et al. 2008).Two possible 
explanations for this discrepancy would be that trace amounts still left in the parasites upon 
downregulation are enough to ensure parasite survival, or alternatively PFA0660w could not be 
essential after all. To clarify this, PFA0660w was targeted for inactivation via selection linked 
integration targeted gene deletion (SLI-TGD). In this approach, integration of a plasmid via SLI causes 
a serve truncation of PFA0660w by deletion of the sequence encoding the entire substrate binding 
domain of the protein (Figure 51). This would most likely render the chaperone inactive, because it 
would not bind its protein substrate. In an initial step the plasmid ∆PFA0660-SBD was cloned by 
amplification of the PFA0660w-targeting region via KOD PCR (See: 4.1.4) using the primers 
PFA0660w_NotI_F and PFA0660w_MluI_R, digestion (See: 4.1.5) of the vector pSLI-TGD (courtesy 
of Dr. Tobias Spielmann) and insert via MluI and NotI ligation (See: 4.1.9) and transformation into 
PMC E. coli via electroporation (See: 4.1.8). The resulting colonies were screened via colony PCR 
(See: 4.1.4), positive colonies were grown in liquid SB (See: 4.1.6), harvested via mini preparation 
(See: 4.1.1), test-digested (See: 4.1.5) and sequenced (See: 4.1.10). Then a maxi preparation 
(See: 4.1.1) was prepared for transfection (See: 4.1.19) of CS2 parasites. After re-growth of the 
transfectants harbouring the plasmid SLI was executed using neomycin as a selective agent 
(See: 4.1.21). SLI was carried out in triplicate, all of which showed re-growth of parasites after 
neomycin selection. These parasites were analysed in the following experiments and will be referred 
to as CS2∆PFA66-SBD 1-3. 
 
2.5.1 Verification of PFA0660w truncation using integration PCR 
Truncation of PFA0660w in the re-grown, neomycin resistant parasites was verified via integration 
PCR using gDNA extracts from the parasites and restriction digests (See: 4.1.1) as described above 
(See: 2.2). Genomic DNA extracts from the parental cell line CS2 as well as the transfectant cell line 
were used as controls, alongside plasmid DNA and ddH2O control. The gDNA amplification control 
yielded bands from all gDNA extracts suggesting integrity of the samples (Figure 53, Table 6). In 
Figure 51: Strategy for PFA0660w truncation via SLI. Integration of the ∆PFA0660w-SBD plasmid is driven via 
neomycin-selection. 
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contrast to the control cell lines all three integration cell lines showed integration of the plasmid into the 
genome. Further the wild-type locus could not be amplified in all three integration cell lines indicating 
disruption of the locus by integration of the plasmid. Remnant plasmid was detected in all transfectant 
and integrant cell lines. These results suggest that PFA0660w is non-essential for in vitro growth of 
P. falciparum parasites as its severe truncation by SLI-TGD yielded viable parasites. Prolonged cell 
culture of P. falciparum is known to permit deletion of the subtelomeric arm of chromosome 2. Among 
the deleted genes are also the major knob (See: 1.4)  components KAHRP and PfEMP3 which results 
in a “knobless” phenotype (Culvenor et al. 1987; Pasloske et al. 1993; Pologe & Ravetch 1986). Since 
KAHSP40 is located on the telomere side of KAHRP and PfEMP3 its detection ensures stability of 
chromosome 2 (Figure 52). Furthermore, control PCRs and digests verified the presence of KAHRP 
and KAHSP40 (Figure 54, Table 6).  Integrant cell lines were further validated via immunoblotting 
(See 4.1.12) and IFA (See: 2.5.3). 
 
Table 6: Expected band sizes for verification of PFA0660w truncation via SLI. 
PFA0660w 
truncation 
5´Integration 3´Integration Wild-type locus Plasmid 
Primers 
PFA_5´_F 
GFP_54_R 
Not-70_F 
PFA_CR_3´_R 
PFA_5´_F 
PFA_Middle_R 
Not-70_F 
GFP_54_R 
Expected Band 1100 bp 2300 bp 1300 bp 1100 
Enzymes XhoI NotI EcoRI  
Expected Bands 
1020 bp 
80 bp 
1020 bp 
80 bp 
600 bp 
450 bp 
 
Controls KAHRP KAHSP40 
Amplification 
control 
 
Primers 
KAHRP_F 
KAHRP_R 
KAHSP40_F 
KAHSP40_R 
H70_F 
H70_R 
 
Expected Band 550 bp 900 bp 470 bp  
Enzymes BamHI HindIII   
Expected Bands 
490 bp 
60 bp 
670 bp 
230 bp 
  
 
  
Figure 52: Overview of the architecture of one arm of P. falciparum chromosome 2. Loss of KAHRP upon a 
stochastic break of the chromosome would also cause deletion of KAHSP40 and PfEMP3. 
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Figure 53: Integration PCR showing disruption of PFA0660w via SLI-TGD. The parental cell line CS2 was used 
as a control together with the transfectant cell line (T) carrying the (non-integrated) plasmid. 
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Figure 54: PCRs and restriction digests demonstrating presence of KAHRP and KAHSP40 in the 
CS2∆PFA0660w-SBD 1-3 cell lines. PCR products were additionally verified using a restriction digest. 
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2.5.2 Verification of PFA0660w  truncation via Western-blot 
Integrant CS2∆PFA0660w-SBD 1-3 cell lines were verified via Western blot using the parental strains 
CS2 as well as the transfectant cell lines as controls. Late-stage parasites of all strains were purified 
using magnetic cell sorting (See: 4.1.24), then protein extracts were prepared and size separated on 
an polyacrylamide gel (See: 4.1.11). The samples were then investigated in a Western-and immuno-
blot (See: 4.1.12) using an α-GFP(mouse) primary and α-mouse-HRP secondary antibody to 
investigate the fusion protein. α-SERP (rabbit) and α-rabbit-HRP antibodies were used as loading 
controls. In contrast to CS2 all integrant cell lines showed a band most likely representing the 
truncated fusion protein at the expected molecular weight of ~44kDa (Figure 55). Interestingly this 
band was also detectable in the transfectant cell line. Additionally all integrant cell lines displayed a 
band at ~25 kDa. As reported by others for other systems this likely represents cleaved GFP (Jenkins 
et al. 2016). Further experiments were done only with the CS2∆PFA0660w-SBD cell line 1. 
  
Figure 55: Western blot showing the truncated PFA66∆SBD-GFP fusion protein in the CS2∆PFA0660w-SBD 
integration cell lines 1-3 as well as in the transfectant cell line. CS2 were used as a control. Α-GFP (mouse) and 
α-mouse-HRP antibodies were used to investigate the fusion protein, while α-SERP (rabbit) and α-rabbit-HRP 
antibodies were used as loading controls. 
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2.5.3 Export of PFA66ΔSBD-GFP  
Next export of the truncated fusion protein was investigated using IFA (See: 4.1.28) with and α-GFP 
(chicken) primary and an α-Chicken-Cy2 secondary antibody. CS2 was used as controls. DAPI was 
used to visualize parasite nuclei. In accordance with previous PFA66-IFAS (See: 2.3) the GFP-derived 
signal could not be distinguished from background staining of the parental CS2 parasites (Figure 56, 
See: 3.2 for discussion). 
 
2.5.4 iRBC morphology upon PFA0660w truncation (SEM) 
Infected RBC morphologies were investigated in the verified CS2∆PFA0660w-SBD strain via SEM. 
Late-stage parasites of the parental strain CS2 as well as the deletion strain were purified using 
magnetic cell sorting (See: 4.1.24), fixed in glutaraldehyde and prepared for SEM imaging using the 
Heidelberg protocol (See: 4.1.31). The CS2∆PFA0660w-SBD parasites presented deformed, 
elongated knobs, in contrast to the parental CS2 parasite cell line which displayed normal knob 
morphologies (Figure 57, Figure 58). Quantification of knobs density in 10 pictures of both strains 
showed that the CS2∆PFA0660w-SBD reveals significantly less (~25%) knobs compared, to the 
parental cell line CS2 (Figure 58). Additionally the proportion of mutant to non-mutant knobs was 
determined since not all CS2∆PFA0660w-SBD knobs displayed the mutant phenotype. Knobs were 
grouped into three categories 1) normal, small knobs 2) bigger, abnormal knobs and 3) severely 
deformed, elongated knobs (Figure 58). While above 95% of CS2 knobs have a small, normal 
phenotype the percentage of abnormally enlarged and deformed, elongated knobs was increased to 
35% in the CS2∆PFA0660w-SBD cell line (Figure 59, See: 3.8 for discussion). Deformed knobs as 
well as other, intracellular parasite structures were analysed further using transmission electron 
microscopy (See: 2.5.5). 
 
Figure 56: IFA for investigation of export of the truncated PFA66∆SBD-GFP fusion protein. 
Results 
61 
 
  
Figure 57: Knob morphologies of CS2 and CS2∆PFA0660w-SBD parasites investigated via SEM. Marked areas 
are enlarged in Figure 54. 
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2.5.5 Investigating intracellular structures in CS2ΔPFA0660w-SBD (TEM) 
Subcellular structures of CS2∆PFA0660w-SBD were further investigated using transmission electron 
microscopy (TEM). CS2 and CS2∆PFA0660w-SBD late stage parasite were purified via a magnetic 
cell sorting (See: 4.1.24), fixed and prepared for transmission electron microscopy (See: 4.1.32). Both 
normal as well as deformed knobs were found in both samples (Figure 60, Figure 61). However the 
frequency of deformed knobs was higher in the mutant sample and the observed deformations were 
more drastic. Additionally some of the knobs of the truncation cell lines were darker in the images. 
Occasionally angled, stacked or enlarged Maurer´s clefts (See: 1.4) were discovered in 
CS2∆PFA0660w-SBD (Figure 62, See: 3.9 for discussion).  
Figure 58: Normal, small abnormal, enlarged and deformed, elongated knob morphologies observed on CS2 and 
CS2∆PFA0660w-SBD iRBCs via SEM. 
Figure 59: Quantification of knob-density A) and knob-morphologies B) on CS2 and CS2∆PFA0660w-SBD 
iRBCs. Shown: Mean, SD; Statistical analysis via two-tailed t-test. p > 0.05 = non-significant (ns); *p < 0.05; **p < 
0.01; ***p < 0.001 
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 Figure 60: TEM of CS2 showing A, C, D) normal and B) deformed knob morphologies. 
A) B) 
C) D) 
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Figure 61: TEM of CS2∆PFA0660w-SBD showing A) normal and B, C, D) deformed knob morphologies.  
C)
A) B)
D)
Results 
65 
 
 
2.5.6 Localization of parasite marker proteins upon PFA0660w truncation (IFA) 
Parasite gene deletion can cause alteration in the transport and localization of other exported proteins 
(Cooke et al. 2006; Maier et al. 2007). Therefore the localization of a variety of parasite proteins was 
investigated in the mutant CS2∆PFA0660w-SBD via specific antibodies in immunofluorescence 
assays (See: 4.1.28). The parental strain CS2 was investigated in parallel as a control. Also DAPI was 
used to visualize parasite nuclei. As an additional control only the secondary antibodies α-mouse-Cy3 
and α-rabbit-Cy3 were used. This produced only faint fluorescence event at high (2000ms) exposure 
times indicating negligible background (not shown). Localization of the important virulence factor 
PfEMP1 was found to be confined to punctuated structures within the RBC cytosol in both CS2 and 
CS2∆PFA0660w-SBD (Figure 63). Also no differences were observed in the patterns obtained in IFAs 
directed against the J-dot protein PfHSP70x (Figure 63). Similarly no major alterations were observed 
in the signal derived from the PTEX component EXP2 (Figure 63) which localizes to the PVM or a 
selected member of the PHIST family (Figure 63, de Koning-Ward et al. 2009). The Maurer´s clefts 
and tethers marker SBP1 and ring exported protein 2 (REX2) also produced punctuated patterns in 
both cell lines (Figure 64, Figure 65) (Blisnick et al. 2000; Haldar & Mohandas 2007). KAHRP (Figure 
65) and PfEMP3 (Figure 66) are the main knob components and also did not show any prominent 
changes upon PFA0660w truncation (Haase et al. 2009). Close observation of all the KAHRP-derived 
signals (Figure 67) from both strains suggest a tendency towards fewer but brighter KAHRP-spots in 
the deletion strain compared to the parental strain. However, this was not statistically analysed 
(See: 3.10 for discussion).  
Figure 62: Selected structures found during CS2∆PFA0660w-SBD transmission electron microscopy showing A) 
enlarged, F) stacked and C, D) angled Maurer´s cleft as well as sections trough B, C, D, E) deformed and F) 
normal knobs. Structures representing Maurer´s clefts or knobs are highlighted with arrows. 
A)
) 
 A) 
B)
) 
 A) 
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)
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)
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Figure 63: IFA investigating PfEMP1,PfHSP70x and EXP2 localization in CS2 and CS2∆PFA0660w-SBD 
parasites. Channel intensities were adjusted for overlays via thresholding in ImageJ to improve visibility.  
Microscopy settings: DAPI 60 ms, α-PfEMP1 50 ms, α-HSP70-x 50 ms, α-EXP2 50 ms. 
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Figure 64: IFA investigating PHIST A and SBP1 localization in CS2 and CS2∆PFA0660w-SBD parasites. 
Channel intensities were adjusted for overlays via thresholding in ImageJ to improve visibility.  Microscopy 
settings: DAPI 60 ms, α-PHIST A 50 ms, α-SBP1 50 ms. 
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Figure 65: IFA investigating REX2 and KAHRP localization in CS2 and CS2∆PFA0660w-SBD parasites. Channel 
intensities were adjusted for overlays via thresholding in ImageJ to improve visibility.  Microscopy settings: DAPI 
60 ms, α-REX2 500 ms, α-KAHRP 50 ms. 
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Figure 66: IFA investigating PfEMP3 localization in CS2 and CS2∆PFA0660w-SBD parasites. Channel intensities 
were adjusted for overlays via thresholding in ImageJ to improve visibility.   Microscopy settings: DAPI 60 ms, α-
PfEMP3 50 ms. 
Figure 67: KAHRP derived signals obtained in IFAs from CS2 
and CS2∆PFA0666w-SBD parasites. Microscopy settings: DAPI 
60 ms, α-KAHRP 50 ms. 
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3 Discussion 
During blood-stage malaria P. falciparum parasites drastically alter their RBC-host cells in order to 
survive. The changes are induced through the export of several hundreds of parasite proteins to 
various compartments of the infected erythrocyte (Hiller et al. 2004; Marti et al. 2005; Sargeant et al. 
2006). Until recently, study of essential genes involved in P. falciparum protein trafficking and host cell 
remodelling has been hampered by lack of conditional knockout system (de Koning-Ward et al. 2015). 
However, now several new systems were introduced including the glmS system which is based on 
GlcN-induced self-cleavage of the glmS ribozyme (Prommana et al. 2013; Winkler et al. 2004). The 
aim of this study was to explore the effect of GlcN dependent downregulation of the four genes 
PFA0660w, GEXP18, CBP1 and PfJ23 via the glmS system. To this end a glmS sequence was 
integrated 3´ of the coding regions of these genes. Additionally, control cell lines were generated were 
glmS ribozyme had been replaced with an inactive version: M9. This was also an examination of the 
glmS system to assess whether or not it would facilitate investigation of larger groups of genes. 
 
3.1 Generation of transgenic glmS and M9 cell lines 
Modification of GEXP18 with glmS and M9 via selection linked integration produced interesting results. 
Single clones consistently yielded bands during integration PCR indicating the presence of the 
modified GEXP18 locus, wild-type GEXP18 locus as well as episomal plasmid in a single 
P. falciparum genome (See: 2.2.2). Similar results have previously been obtained by others for other 
genes (such as PV1) and were interpreted as evidence for gene duplication (Chu et al. 2011; Maier et 
al. 2008). While this is an interesting phenomenon it also means that this cell line could not be used in 
further experiments, because the non-modified wild-type locus would compensate any effects elicited 
by the downregulation of the modified gene. One explanation for these results is that GEXP18 is an 
essential gene and its modification through integration of the plasmid is disruptive to its functionality. 
Possibly addition of the gfp tag or alteration in GEXP18 expression levels or patterns through 
exchange of the 3´ UTR and/or integration of glmS or M9 could impose these changes. If this would be 
the case application of the second selective agent during SLI might lead to the selection of parasites 
with a duplicated GEXP18 locus, with one wild-type copy compensating for the otherwise lethal 
modification of the other. While this is would likely be a rare event, SLI could allow the selection of rare 
parasite genotypes from a large starting population. Alternatively integration of the plasmid could be 
detrimental to other essential P. falciparum genes located in the vicinity of GEXP18. Similarly to the 
previously described model this could lead to duplication of this region of the chromosome, with the 
exception that GEXP18 duplication would be a by-product of duplication of a different, essential locus. 
For the three other genes integrations via SLI were readily obtained (See: 2.2.4, 2.2.3, 2.2.4), 
indicating that this is not an inherent issue of the SLI system. Further analysis could target GEXP18 for 
inactivation via SLI-TGD and/or conditional knockout/knockdown with a different genetic system. 
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3.2 Export of fusion proteins 
Export of the PFA66, CBP1 and PfJ23 fusion proteins was investigated in glmS and M9 cell lines via 
immunofluorescence assay using antibodies directed against the GFP tag (See: 2.3, 2.5.3). The 
CBP1-GFP fusion protein localizes in both strains to punctuated structures, which might represent 
Maurer´s clefts. Other studies localized CBP1 to the surface of infected erythrocytes. However 
intracellular localization of CBP1 was not subject of previous investigations (Hermand et al. 2016). As 
reported for other proteins destined for the host cell surface like PfEMP1, CBP1 might associate with 
the Maurer´s clefts en route to the iRBC surface (Mundwiler-Pachlatko & Beck 2013).  
PfJ23 was detected in similar punctuated structures in the glmS cell line consistent with its localization 
to Maurer´s clefts like previously published (Vincensini et al. 2005). No PfJ23-signal could be detected 
in the M9 cell line. Since the signal observed in the glmS cell line seemed to be barely above the 
detection limit of the technique, this might be due to an even lower expression level of the fusion 
protein in the M9 cell line as can be seen the PfJ23-regulation experiments (See: 2.4.3). Identity of the 
punctuated structures observed in CBP1 and PfJ23 IFAs could be investigated through co-localization 
experiments using parasite marker proteins.  
Neither the full-length nor the truncated PFA66 fusion protein could be detected via IFA. As expression 
driven by endogenous promoters can be very weak this might be due to expression of the fusion 
protein below the detection limit (Birnbaum et al. 2017). Previous studies showed export of PFA66-
GFP in parasites with a similar genetic makeup like he parasites used in this study, demonstrating that 
introduction of the GFP tag should not interfere with PFA66 trafficking to the J-dots (Petersen et al. 
2016). Possibly, integration of glmS and M9 might decrease PFA66 expression below detection level. 
 
3.3 GlcN dependent gene regulation via glmS 
To investigate GlcN dependent downregulation of the genes PFA0660w, CBP1 and PfJ23 cultures of 
the glmS-modified cell lines were split into two. Then one culture was treated with GlcN while the other 
one was treated with the solvent (ddH2O) for 48 h. The respective M9 cell lines were treated in parallel 
as controls. Then protein extracts were prepared from purified parasites and fusion protein abundance 
was investigated via immuno-blot and compared with the three loading controls SERP, GLYCO and 
EXP1. The results show that GlcN treatment significantly and reliably downregulated expression of all 
three fusion proteins in the glmS cell lines to ~10% (PFA0660w, See: 2.4.1), ~ 5% (CBP1, See: 2.4.2) 
or ~20% (PfJ23, See: 2.4.3) of the ddH2O-treated glmS control. These results are in line with the 
regulation efficiencies achieved by Prommana or Elsworth et al. using the same system (Elsworth et 
al. 2014; Prommana et al. 2013). Importantly, this establishes the glmS system in our lab and opens 
up the possibility to apply the system for regulation of further genes. However, regulation dynamics in 
the glmS and M9 cell lines were different for all three genes. 
The PFA0660w regulation experiment showed downregulation upon integration of glmS compared to 
M9. It is conceivable that the active glmS ribozyme could be triggered by endogenous GlcN present in 
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the parasites and thus trigger glmS cleavage and downregulation. Interestingly, this effect was not 
observed (CBP1) or even reversed (PfJ23) for the other two genes.  
Puzzlingly, integration of glmS caused an upregulation of PfJ23 expression when compared to the M9 
control. A possible explanation could be that the M9 ribozyme adopts a different fold than the active 
glmS ribozyme, which might impact PfJ23 protein production. Interestingly, treatment with GlcN 
caused an upregulation of the PfJ23 fusion protein in the M9 cell line. Since effects of GlcN treatment 
on parasite gene expression have already been reported, this might be a bona fide effect of GlcN 
treatment on PfJ23 gene expression (Prommana et al. 2013).  
In the case of CBP1 none of these effects were observed, since there was no significant difference in 
fusion protein abundance between GlcN and ddH2O treated M9 as well as ddH2O treated glmS cell 
lines.  
Surprisingly, all three genes display varying GlcN dependent regulation dynamics. As the used 
plasmids for generation of the cell lines were almost identical apart from the gene targeting region the 
reason for this might be the genetic environment into which the plasmids were inserted. It should also 
be noted that integration of the plasmids, introduction of intricately folded ribozymes into the transcript 
as well as exchange of the 3´UTR is also likely to affect target gene expression. These changes might 
prohibit modification of some genes via this system (e.g. GEXP18, See: 3.1).  
 
3.4 Gene modification via selection-linked-integration 
During these regulation experiments it was noted that the glmS and M9 cell lines generated via 
selection linked integration (CBP1 and PfJ23) displayed a double band in the α-GFP immuno-blot 
(Figure 42, Figure 47). The lower of these bands constitutes the expected fusion protein, while the 
other one likely represents non-skipped fusion protein (Figure 10). Furthermore, the two genes 
showed differences in the ratio of skipped to non-skipped peptides, implying that the skipping-
efficiency might be gene-specific. As non-skipped fusion proteins with exported proteins should also 
be exported to the host cell this might lead to export of a proportion of the resistance marker. 
Importantly, this could interfere with the generation of integration cell lines via SLI for some genes. 
Furthermore it is conceivable that integration of an even larger tag than GFP might additionally 
interfere with protein functionality. Interestingly, this problem was not reported in the original SLI-paper 
(Birnbaum et al. 2017). As skipping efficiency seems to be dependent on the genetic context around it 
using the original plasmid designed by Birnbaum et al. might be beneficent. Notably, generation of the 
CS2∆PFA0660w-SBD cell line showed no deficiency in skipping (Figure 55). However, similar 
problems have been reported by other working groups, even when using the original plasmids 
(personal communication: Dr. Moritz Treeck). Therefore exploring alternative skipping peptides and/or 
the use of multiple skipping peptides might solve the problem, however at the risk of affecting selection 
marker expression. Despite this use of selection-linked-integration significantly speeds up the process 
of P. falciparum mutant generation. 
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3.5 Effects of GlcN dependent regulation of PFA0660w, CBP1 and PfJ23 
Since all three genes enabled GlcN dependent downregulation in the glmS cell line potential effects on 
parasite viability were investigated via Giemsa-stained smears and Plasmodium lactate 
dehydrogenase assay. Downregulation in all three cell lines neither affected parasite morphology nor 
growth in a drastic way, which would imply that PFA0660w (See: 2.4.1.2), CBP1 (See: 2.4.2.2) and 
PfJ23 (See: 2.4.3.2) are dispensable for in vitro growth of the parasites. Non-essentiality of PFA0660w 
was further substantiated by severe truncation of the gene using SLI-TGD (See: 2.5). Also CBP1 
deletion by another working group demonstrates that the gene is dispensable (Prof. Dr. Leann Tilley 
unpublished). Alternatively, the residual protein levels upon downregulation of PfJ23 could be 
sufficient to fulfil its function, even if the gene is essential. Reports for the parasites protease 
Plasmepsin V indicated that 4-10 fold downregulation does not affect parasite viability (Gambini et al. 
2015). Later reports demonstrated essentiality of Plasmepsin V via conditional knockout, implying that 
PfJ23 could follow similar dynamics (Boonyalai et al. 2018). Likewise, reports by another working 
group showed that strong downregulation of an N-acetyltransferase was not detrimental to the parasite 
growth. However the gene was also resistant to deletion, indicating that it is nevertheless essential 
(personal communication: Dr. Cecilia Sanchez). Targeting of PfJ23 via SLI-TGD and/or DiCre would 
likely help to clarify if the gene is essential or dispensable. 
Downregulation of PFA0660w did not induce observable changes in iRBC cytoadherence 
(See: 2.4.1.4.2) nor iRBC rigidity (See: 2.4.1.5.2). For iRBC rigidity this may have technical reasons. 
The artificial spleen assay was successfully established using CS2 parasites. However experiments 
using the transgenic cell lines always showed too high retention rates. This could be due to the fact 
that parasitemias for these experiments were determined using flow-cytometry to reduce work load 
while earlier experiments were done with Giemsa-stained smears. Alternatively, variations in the 
thickness of the microbead layer might be responsible as this was not properly monitored.  
Furthermore downregulation of PFA0660w or CBP1 did not induce drastic changes in knob 
morphology when observed by scanning electron microscopy (See: 2.4.1.3, 2.4.2.3). Interestingly 
unpublished data by Prof. Dr. Leann Tilley indicates that deletion of CBP1 leads to severely deformed 
knob morphologies. Similarly PFA0660w deactivation via severe truncation using SLI-TGD caused 
drastically elongated knobs (See: 2.5.4). Since this was not observed when these genes were strongly 
downregulated via the glmS system, the achieved downregulation is likely too low. Alternatively, the 
downregulation of PFA0660w caused by integration of the glmS may cause upregulation of other 
HSP40s which may have a complementary function. This effect might not occur in the 
CS2∆PFA0660w-SBD cell line 
 
3.6 Study of gene functionality via glmS 
A few conditions must be fulfilled to enable study of a gene via the glmS system. First of all, integration 
of the plasmid and possible concomitant changes in gene expression cannot be lethal to the parasite. 
Additionally GlcN dependent downregulation of the gene has to be strong enough to impact its 
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functionality. For the study of non-essential genes it might be more straightforward to use genetic 
deletions, as these would not require the use of as many controls like the same analysis via the glmS 
system. Also one would not run the risk of “missing” a mutant phenotype due to insufficient knock-
down of gene expression. An exception might be, when “tunability” of a mutant phenotype via the GlcN 
concentration is desired. Analysis of essential genes might –depending on the gene– require stronger 
regulation. In theory, this could be achieved through the use multiple glmS ribozymes in tandem, 
which would give rise to a more “digital” switch. Also 5´ instead of 3´ integration of the glmS sequence 
might increase regulation efficiency, because the de-capped mRNA would then be degraded by the 
faster acting 5´-3´exonucleaseses rather than the slower acting exosomes (Meaux & Van Hoof 2006). 
However 5´ integration might also impact on gene expression by itself, since the complex fold of the 
ribozyme might interfere with ribosome scanning and additionally is difficult to accomplish in 
P. falciparum  (de Koning-Ward et al. 2015; Ringnér & Krogh 2005). Alternatively other ribozymes or 
riboswitches could be explored for the use in P. falciparum. Tetracycline and theophylline responsive 
hammerheads for instance have already been used in other systems (Townshend et al. 2015; 
Wittmann & Suess 2011). High-priority essential targets could also warrant investigation via the 
recombinase based DiCre system (Collins et al. 2013). 
 
3.7 PFA0660w truncation via SLI- TGD 
Severe downregulation of PFA0660w via the glmS system did not affect parasite viability, although 
previous data indicated that it is essential (See: 1.8, 2.4.1.2). There could be two possible 
explanations for this: 1) PFA0660w is essential, but the residual protein left in the parasites upon 
knockdown may be enough to fulfil its function or 2) PFA0660w is actually non-essential. To 
investigate this PFA0660w was targeted for severe truncation using SLI, which would cause the 
removal of the entire substrate binding domain (SBD) of the finished protein. Removal of the SBD 
would negate binding of PFA66 to its substrate, which most likely renders the HSP40 non-functional. 
Furthermore J-dot targeting of the similar type II HSP40 PFE55 relies on its SBD (Petersen et al. 
2016). If PFA66 is exported in a similar manner to PFE55, faulty trafficking upon SBD truncation could 
also impact on its functionality. Truncation of PFA0660w was successful and lead to viable parasites 
expressing truncated PFA66 as demonstrated by integration PCR (See: 2.5.1) and immuno-blot 
(See: 2.5.2). Therefore PFA0660w should be considered non-essential. It would be interesting to 
investigate parasite morphology in highly synchronized parasites upon PFA0660w truncation via 
Giemsa-stained smears. 
 
3.8 Knob morphology upon PFA0660w truncation 
Investigation of knob morphologies upon truncation of PFA0660w in the strain CS2∆PFA0660w-SBD 
via scanning and transmission electron microscopy showed severely deformed and elongated knob 
morphologies in the CS2∆PFA0660w-SBD strain (See: 2.5.4). This was a gradual phenotype, as 
occasionally similar structures could be observed in the parental CS2 strain albeit at a much lower 
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frequency. The truncation strain also demonstrated overall lower knob numbers (See: 2.5.4). 
Complementation of the CS2∆PFA0660w-SBD strain through episomal expression of full-length 
PFA0660w could help to further validate the mutant phenotype. According to in vitro data, PFA66 is a 
co-chaperone of the exported plasmodial HSP70 PfHSP70x. Interestingly, PfHSP70x deletion had no 
observable effect on knob morphology (Charnaud et al. 2017). While this does not contradict the 
interaction of PFA66 and PfHSP70x it might indicate that PFA66 also serves other in vivo functions 
which are removed from its interaction with PfHSP70x. From other systems HSP40s are known to 
interact with and regulate the activity of HSP70s, which are themselves involved in the folding, 
transport, stabilization, degradation and assembly of proteins and protein complexes (Lemmon 2001; 
Shonhai 2010). Thus a function of PFA66 during complex assembly, like knobs, would harmonize 
known functions of HSPs together with the observed mutant phenotype upon PFA0660w inactivation. 
This could also be in concert with other HSP70s in the host cell, like human HSP70s. In SEM the 
truncation strain also demonstrated overall lower knob numbers. Possibly, this could indicate that the 
same amount of material is packed into fewer knobs leading to deformation. The observation that 
mutant knobs often appeared more electron-dense during transmission electron microscopy would 
support this (See: 2.5.5). There are also other exported parasite HSP40s associated in with knobs. 
Deletion of the HSP40 Pf10_0381 by Maier et al. caused small, rudimentary knob morphologies. Also 
KAHSP40 localizes to the knobs and is thought to be involved in chaperoning knob assembly. 
However deletion of KAHSP40 had no drastic effect on knob formation (Acharya et al. 2012; Maier et 
al. 2008). A study investigating knob morphologies of infected erythrocytes from patients suffering 
from haemoglobinopathies (sickle cell anaemia and α-thalassemia) showed similar deformations, due 
to a delay in protein trafficking in the haemoglobinopathic erythrocytes (Kilian et al. 2015). It would be 
interesting to investigate knob morphologies upon infection of these RBCs with parasites with 
PFA0660w truncation. According to unpublished data by Prof. Dr. Leann Tilley deletion of CBP1 
caused similar deformations in knob morphologies. Dual deletion of both CBP1 and PFA0660w could 
provide evidence if this occurs through similar or distinct mechanisms.  
 
3.9 Investigation of internal organization of the strain CS2∆PFA0660w-SBD  
Internal organization of the strain CS2∆PFA0660w-SBD was investigated via TEM. During TEM 
stacked as well as angled Maurer´s clefts were observed beneath deformed knobs in the PFA0660w 
truncation strain (See: 2.5.5, Figure 5). Stacked Maurer´s clefts are a frequent observation in gene 
deletion mutants like ∆REX1, but also occur in wild-type parasites with strain specific frequency 
(Hanssen et al. 2007, 2008; Wickert et al. 2004). Angled Maurer´s clefts are a much rarer 
phenomenon and it is intriguing to speculate that Maurer´s clefts in their presumed role as assembly 
stations for knobs might contribute to these drastic deformations (Hanssen et al. 2007). While PFA66 
does not directly localize to the Maurer’s clefts it could impact these indirectly, i.e. through the 
transport of a factor. Alternatively, possible altered Maurer´s clefts morphologies might be a side 
effect, rather than the cause of the knob deformations. However careful quantification of stacked 
Maurer´s clefts with a larger sample size and ideally treatment of a complementation cell line in 
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parallel would be required to make any definite conclusion about the involvement of Maurer´s clefts. If 
differences are found immuno-TEM using various Maurer´s clefts marker might help to further dissect 
these. 
3.10 Investigation of parasite marker proteins in the strain CS2∆PFA0660w-SBD  
Since PFA66 might be involved in the export of other parasites proteins to the host cell localization of 
various marker proteins was investigated in the PFA0660w truncation strain (See: 2.5.6). Overall no 
drastic differences in localization of the marker proteins of the Maurer´s clefts, tethers, knobs and J-
dots was found, indicating that PFA0660w inactivation had no global effect on protein trafficking. 
Potential, gradual changes were observed in KAHRP localization between the mutant and parental 
cell line, but remain to be quantified. There seemed to be a tendency for bigger, brighter spots in the 
mutant cell line, which is in accordance with the observed knob deformations. However, these remain 
to be quantified. Alternatively, drastic knob deformations could lead to loss of KAHRP-derived signals 
in the IFAs which could have potentially biased the analysis. J-dots are thought be involved in PfEMP1 
trafficking as HSP70x binds to PFA66 as well as PfEMP1 in vitro. There was no obvious difference in 
PfEMP1 localization between mutant and parental cell lines, indicating that at least the majority of 
PfEMP1 is trafficked in a PFA66 independent manner. However, PfEMP1 was detected in the 
Maurer´s clefts en route to its final destination: the erythrocyte surface. Therefore differences in this 
last translocation step of PfEMP1 to the RBC surface cannot be excluded. More detailed microscopy 
methods might help to identify more gradual changes in marker protein localization in the mutant. Also 
surface exposure of PfEMP1 could be analysed via flow-cytometry. The deformed knob morphology is 
also likely to impact cytoadherence and iRBC rigidity, which could be analysed using CSA binding and 
microfiltration assays. Also the structural organization of the cytoskeleton underlying the massively 
deformed knobs could be analysed using e.g. correlative stochastic optical reconstruction microscopy-
scanning electron microscopy (STORM-SEM). This relies on correlation of super resolution fluorescent 
microscopy with SEM and was previously used to investigate KAHRP assembly during knob formation 
(Looker et al. 2019). 
 
3.11 Conclusion 
In conclusion during this project the genes PFA0660w, CBP1, and PfJ23 were successfully modified 
with a glmS sequence, while targeting of the gene GEXP18 lead to its duplication. GlcN dependent 
downregulation of PFA0660w, CBP1, and PfJ23, although reliable, caused no observable defects in 
the parasites. However, inactivation of PFA0660w did cause severe deformation and elongation in 
iRBC knob morphology, indicating that the downregulation achieved via the glmS system was not 
strong enough to observe this phenotype. While the glmS system was used successfully by others to 
regulate genes and investigate the effect, its effectivity is likely gene-specific and poorly predicable. 
Therefore its use should be restricted to high-priority targets and alternative systems should be 
considered. To end on a positive note, inactivation of PFA0660w via SLI-TGD caused fascinating 
changes in iRBC morphology which warrant further investigations. 
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4 Material and Methods 
4.1 Methods 
4.1.1 Kits for DNA purification 
Small preparations of plasmid DNA (approximately 2.5 µg) were prepared with a peqGOLD Miniprep 
Kit I (Peqlab) according to the specifications of the supplier. 2 ml of E. coli overnight culture were 
subjected to alkaline lysis. Then the freed plasmid DNA was bound to a silica membrane, washed and 
finally eluted.  
Big preparations of plasmid DNA (approximately 500 µg) were prepared with a Plasmid Maxi Kit 
(Qiagen) according to a protocol slightly modified from the specifications of the supplier. 400 ml of 
overnight E. coli culture were pelleted, resuspended in 20 ml of resuspension buffer, lysed with 20 ml 
of alkaline lysis buffer for 5 min and neutralized with 20 ml of neutralization buffer for 20 min on ice. 
The resulting lysate was centrifuged for 30 min at 20.000 g at 4°C. Afterwards the supernatant was 
applied to the column through a filter to avoid clogging of the column. Washing, elution and 
precipitation of the plasmid DNA was executed according to the Qiagen protocol and finally DNA was 
solved in 1500 µl of TE buffer. 
TE Buffer 
10 mM Tris/HCl 
1 mM EDTA 
pH adjusted to 8.0 
 
Extraction of P. falciparum gDNA was performed using the Qiaamp Mini kit (Qiagen) following the 
protocol of the supplier. Approximately 1x10
8
-1x10
9
 of saponin treated (See: 4.1.23) parasites were 
lysed enzymatically using proteinase K, gDNA was then bound to a silica- membrane, washed and 
finally eluted. 
Furthermore a gel extraction kit (Peqlab) was used to extract DNA from cut agarose gels and a PCR 
cleanup kit (Peqlab) was used to purify DNA from PCR reactions. 
 
4.1.2 DNA precipitation 
DNA is very water-soluble due to its high polarity. Addition of larger amounts of ethanol to DNA in 
aqueous solution causes disruption of the hydration shell around ions. This allows the formation of 
ionic bonds between the phosphate backbone of the DNA and positively charged ions leading to 
precipitation of the DNA from the solution. Prior to transformation of E. coli or transfection of P. 
falciparum plasmid DNA was precipitated through the addition of 2x volumes cold (-20°C) 
100% ethanol and 0.1x volumes 3 M Na- acetate (pH 5.2). After centrifugation at 36.000 g at 4°C for 
30 min the supernatant was discarded and DNA was washed with 500 µl of 70% Ethanol. Following 
careful removal of the supernatant the pellet was dried for 10 min at 50°C (transformation) or under 
sterile conditions (transfection). Afterwards DNA was solved in 10 µl of ddH2O (transformation) or 
30 µl TE (transfection) at 50°C for 10 min with shaking (~200 rpm). 
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4.1.3 Agarose gel electrophoresis 
The negatively charged phosphate backbone of DNA causes it to migrate towards the positive pole in 
an electromagnetic field. This property of DNA is used during agarose gel electrophoresis to achieve 
size separation of linear DNA fragments. Firstly DNA is mixed with 6x loading dye, applied to an 
agarose gel and a small electric field is engaged which causes the DNA fragments to travel through 
the gel. Migration of smaller DNA fragments is less hindered by the dense mesh formed by the 
agarose than larger DNA fragments, therefore smaller DNA fragments travel faster through the gel 
than bigger fragments resulting in size- separation of the fragments. Comparison of these fragments 
with a DNA size standard (Figure 68) run in parallel to the DNA samples then allows judgement of 
DNA fragment size. For visualization DNA is stained using the fluorescent dye ethidium bromide. 
Fluorescence of ethidium bromide is strongly increased upon intercalation into DNA and excitation by 
UV light. Agarose gels were run at 110-140 V, 500 mA for 30-50 min in TAE buffer and then visualized 
at a UV table.  
Agarose gel preparation 
0,8-2% (w/v) agarose was solved in TAE buffer by boiling in a microwave. The resulting gel was mixed 
with ethidium bromide (f.c. 50 ng/ml), poured into a gel form and used after solidification at RT. 
 
TAE buffer  6x Loading dye 
40 mM Tris 50 mM Tris/HCl   
40 mM Acetic acid 5 mM EDTA 
1 mM EDTA  30% (v/v) Glycerol 
 1% (w/v) Bromophenol blue 
 pH adjusted to 8.0 
 
Size standard 
 
 
 
 
 
 
Figure 68: 1 kb + DNA size- standard 
(https://www.fishersci.co.uk) 
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4.1.4 Polymerase chain reaction (PCR) based methods 
Polymerase chain reaction enables the multiplication of DNA fragments from a template DNA via the 
extension of short DNA-oligomers, the so-called primers, by a DNA-polymerase in a temperature-
cycling reaction. Firstly, in the denaturation step, heating of the reaction to 95°C denatures template 
strands and primers alike, causing a separation of the DNA strands. Subsequent cooling of the 
reaction to 45-55°C allows specific binding of the primers to complementary binding sites at the 5´ and 
3´ end of the desired PCR product. Elevation of the temperature in the elongation step to 68°C allows 
elongation of the primers by the DNA polymerase from the 3´ end. Under ideal circumstances this 
allows doubling of the product- amount in every cycle. Two DNA-polymerases were used in this 
project: KOD polymerase and self-made Taq polymerase. KOD PCR was used during cloning for the 
production of insert. Also colony PCR was used for the screening of E. coli colonies after 
transformation of a ligation. Predominantly Taq polymerase was used for verification of P. falciparum 
integrants with the integration PCR program. When larger amounts of product were necessary to allow 
digestions KOD polymerase was used for integration PCR.  
KOD: Typical reaction  KOD PCR program 
5 µl of 10xKOD Buffer  1) Initial denaturation: 95° C, 10 min 
0.8 mM dNTP-mix  2) Denaturation step: 95°C, 1 min 
1.5 mM MgSO4  3) Annealing step: 45-55°C, 1 min 
25 pmol Forward/ reverse primer  4) Polymerization step: 68°C, 30s/kb 
1 U KOD polymerase  5) Final polymerization: 68°C, 10min 
Ad 50 µl with PCR- grade H2O  6) Pause- step: 4°C, ∞ 
 
 
 
 
Up to 
39 cylces 
Figure 69: Repeated cycles of 1) Denaturation, 2) Annealing and 3) elongation steps lead to a fast multiplication 
of product in the PCR. Brakeage of hydrogen bonds during the denaturation step allow the annealing of specific 
5´ and 3´ primers to complementary sequences on the template strand. The 3´ end of the primers is then 
elongated by the DNA polymerase during the elongation step (https://www.abmgood.com). 
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Taq: Typical reaction  Taq PCR program 
5 µl of 10xTaq Buffer  1) Initial denaturation: 95° C, 6 min 
0.2 mM dNTP-mix  2) Denaturation step: 95°C, 1 min 
25 pmol forward/ reverse primer 3) Annealing step: 45-55°C, 1 min 
1 µl self-made Taq polymerase 4) Polymerization step: 68°C, 60s/kb 
1 U KOD Polymerase  5) Final polymerization: 68°C, 10min 
Ad 50 µl with PCR- grade H2O  6) Pause- step: 4°C, ∞ 
 
Taq Buffer   Integration PCR Program 
200 mM Tris/HCl 1) Initial denaturation: 95° C, 5 min 
100 mM KCl 2) Denaturation step: 94°C, 30 s 
100 mM (NH4)2SO4 3) Annealing step: 45°C, 50 s 
20 mM MgSO4 4) Polymerization step: 60°C, 8 min 
1% Triton X-100 5) Final polymerization: 60°C, 8 min 
pH adjusted to 8.8 6) Pause- step: 4°C, ∞ 
 
Colony PCR 
Colony PCR was used as a screening for E. coli colonies carrying the desired plasmid after 
transformation of a ligation. Primers were selected to only produce a product upon correct integration 
of the insert into the vector. Then E. coli colonies were first rescued on a LB petri dish and a part of the 
material was transferred to a colony reaction. The PCRs were run and investigated with an agarose 
gel. 
Typical reaction  Colony PCR program 
25 µl of Colony mix  1) Initial denaturation: 95° C, 10 min 
50 pmol Forward/ reverse primer 2) Denaturation step: 95°C, 1 min 
0.5 µl Self- made Taq polymerase 3) Annealing step: 45°C, 1 min 
E. coli colony material 4) Polymerization step: 68°C, 2 min 
 5) Final polymerization: 68°C, 10min 
 6) Pause- step: 4°C, ∞ 
 
Colony Mix  Cresol red solution 
1 ml Cresol red solution  0.1 g o-Cresolsulfonephatlein 
600 µl 10x Taq buffer  60% Sucrose (w/v) 
0.2 mM dNTPs ad 10 ml ddH2O 
Ad 6 ml ddH2O 
 
 
 
 
 
 
 
Up to 
39 cylces 
50 cylces 
Up to 
35 cylces 
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4.1.5 Digestion of DNA 
Restriction enzymes recognize and cleave specific (usually palindromic) DNA sequences. This can be 
used for cloning or verification of the identity of a DNA fragment. All used restriction enzyme were 
obtained from New England Biolabs and used according to NEB specifications: 
DNA analysis  Cloning 
 ~ 0.8 µg plasmid DNA or  ~2 µg plasmid DNA 
~ 0.4 µg of PCR product 5 µl 10xCutSmart Buffer 
2 µl 10xCutSmart Buffer  5 U of Enzyme(s)  
2.5 U of Enzyme(s)  Ad 50 µl ddH2O  
Ad 20 µl ddH2O  
 
4.1.6 Escherichia coli cultivation 
E. coli were grown in liquid culture at 37°C overnight with shaking at 200 rpm in super broth medium 
or on petri-dishes containing LB-Agar at 37°C overnight. Plasmid carrying E. coli were selected with 
50 µg/ml ampicillin. 
Super broth (SB) medium 
35 g/l Peptone 
20 g/l Yeast extract 
4 g/l NaCl 
5 mM NaOH  
 
4.1.7 Preparation of electrocompetent Escherichia coli 
Electric pulses can create pores in the bacterial membrane of E. coli allowing the uptake of 
extracellular DNA. This is commonly used to generate plasmid carrying transgenic E. coli.  To prepare 
electrocompetent cells an overnight culture was diluted 1:100 in fresh SB medium and grown for 
~3.5 h to an OD600 of 0,4-0,6. The cells were then cooled down on ice for 10-15 min, harvested at 
4000 g for 10 min at 4°C and washed three times with 0,5 culture volumes of ice cold ddH2O and once 
with 0,5 culture volumes of ice-cold 10% glycerol (v/v) in ddH2O. Cells were then resuspended in 
0,002 culture volumes of 10% glycerol in ddH2O, aliquoted, shock frozen in liquid nitrogen and kept for 
long-term storage at -80°C. 
SB Medium 
See: 4.1.6 
 
4.1.8 Transformation of electrocompetent E. coli 
For transformation electrocompetent E. coli were tawn on ice. Then 50 µl of cells were joined with up 
to 10 µl of ddH2O containing the DNA and transferred to a cuvette (0.2 mm gap). Electroporation was 
executed at 2,5 kV, 25 µF capacitance and 200 Ω. Cells were then mixed with 1 ml of SOC medium 
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and allowed to recover for 1 h at 37°C with 200 rpm shaking before plating onto a petri dish containing 
LB-Agar. 
Super optimal broth (SOB)    Super optimal broth with catabolite repression (SOC) 
26.64 g/l SOB powder SOB Medium 
 20 mM Glucose 
 
4.1.9 Ligation 
Ligase catalyses the joining of free 3´ hydroxyl and 5´ phosphate ends of nucleic acids. This can be 
used to ligate an insert into a vector if both feature compatible ends. Commonly vector and insert are 
supplied to the reaction in a 1:3 ratio. Ligations were incubated overnight at 16°C. 
Ligation reaction 
X mol of Vector 
3x mol of Insert 
2 µl Ligase Buffer 
1 U T4 Ligase 
Ad 10 µl ddH2O 
 
4.1.10  DNA sequencing 
To-be-sequenced DNA was send together with the respective primers to GATC Biotech for Sanger 
sequencing, according to GATC specifications. 
 
4.1.11  SDS-gel electrophoresis 
SDS-gel electrophoresis allows the separation of proteins according to their molecular weight in a 
polyacrylamide gel by an electric field. Firstly proteins are denatured through the application of heat 
and disulphide bonds are broken through the addition of a reducing agent: Dithiothreitol (DTT). 
Accurate size separation, without influence of the proteins native charge is achieved through the 
addition of the anionic detergent sodium dodecyl sulphate (SDS), which linearizes the denatured 
proteins and adds negative charge in proportion to the proteins molecular weight. Discontinuous gel 
systems consist of two phases: the stacking and separating gel. In the stacking gel the protein in the 
sample are squeezed between glycine ions from the running buffer and Cl
-
 ions from the stacking gel. 
Proteins are therefore highly concentrated when they migrate through the stacking gel, which yields 
more defined bands on the gel. Release of the glycine-Cl- lamp due to pH-change pH upon entry into 
the separating gel allows size separation of the proteins. Smaller proteins are less retained by the 
polyacrylamide gel then larger proteins, causing smaller proteins to migrate faster. Comparison with a 
MW standard (Figure 70) then allows judgement of protein molecular weights. Protein samples 
(usually ~1x10
8
 MACS purified (See: 4.1.24) parasites in 50 µl PBS) were mixed with 2xSDS loading 
buffer, boiled for 10 min at 99°C, spun down at 30,000 g for 10 min at 4°C and a volume of the 
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supernatant corresponding to ~1x10
7
 parasites was applied per lane. Gels were run at 90 V until 
proteins passed the stacking gel. Then voltage was increased to 120 V. Size separation was 
completed when the blue dye front reached the end of the gel. 
Loading buffer  Running buffer 
100 mM Tris/HCl  960 mM Glycine 
100 mM DTT  124 mM Tris 
20% (v/v) Glycerol  0.05 (w/v) SDS 
5 mM EDTA 
4% (w/v) SDS 
0.2% (w/v) Bromophenolblue 
pH adjusted to 6.8 
Stacking gel buffer Separating gel buffer 
500 mM Tris/HCl  1.5 M Tris/HCl 
0.4% (w/v) SDS  0.4% (w/v) SDS 
pH adjusted to 6.8  pH adjusted to 8.8 
 
Stacking gel  Separating gel (10%) 
2.9 ml ddH2O  4.2 ml 30% H2O 
1.25 ml Stacking buffer  2.5 ml Separating buffer  
0.83 ml 30% Acrylamide  3.3 ml 30% Acrylamide 
50 µl APS solution  80 µl APS solution 
3.8 µl TEMED  6 µl TEMED 
Ammonium Peroxodisulfate solution (APS) 
10% (w/v) APS in ddH2O 
Molecular weight standard 
 
 
 
 
 
Figure 70: PageRuler Prestained 
Protein Ladder from Thermo Scientific 
(https://www.thermofisher.com) 
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4.1.12  Semi-dry Western- blot and immunoblotting 
Western blot allows detection of proteins on a nitrocellulose membrane via a primary antibody directed 
against the protein of interest and a second antibody is used to detect the primary antibody (Towbin et 
al. 1979). The secondary antibody is directed against epitopes featured on the primary antibody which 
allows enhancement of the signal. Additionally the secondary antibody is conjugated to a horse-
reddish peroxidase which is used for detection. First, proteins were size separated on a SDS gel 
(See: 4.1.11) and then transferred to a nitrocellulose membrane via semi-dry western blotting. For this 
a transfer buffer drenched filter sandwich was prepared (Figure 71) with three Whatman papers on the 
bottom, followed by the SDS gel, the nitrocellulose membrane and three Whatman papers. Application 
of a small electric field then causes migration of the negatively charged proteins though the filter 
sandwich until they are captured by the nitrocellulose. Western blotting was executed at 2 mA/cm
2
 of 
gel for 90 min and correct transfer was 
verified by staining with Ponceau. The 
membrane was then blocked with 10 ml 
blocking solution for 1 h at RT and treated 
with the primary antibody in 10 ml of 
blocking solution overnight at 4°C. On the 
next day, the membrane was washed three 
times with 10 ml of PBS (pH 7.4) for 10 min 
each and treated with the secondary 
antibody diluted 1:2000 in 10 ml blocking 
solution. After washing three times with 
10 ml of PBS (pH 7.4) the membrane was 
developed using 1 ml ECL solution with 
0,03% (v/v) H2O2 causing the HRP to emit 
light which was detected on an X-Ray film.  
 
Phosphate buffered saline (PBS)  Transfer buffer 
140 mM NaCl  48 mM Tris/HCl 
2.7 mM KCl  39 mM Glycine 
1.4 mM KH2PO4  20% (v/v) Methanol 
0.8 mM Na2HPO4  0.04% (w/v) SDS 
pH adjusted to 7.4 or 7.2  pH adjusted to 9.5 
Ponceau staining solution  Blocking solution 
0.2% Ponceau S 5% Milk powder in PBS (pH 7.4) 
3% Tri-Chloracetic acid 
 
ECL- solution 
200 mM Tris/HCl 
5 mM p-Coumaric acid 
0.8 mM Luminol 
pH adjusted to 8,5 
 
Figure 71: Setup for transfer of protein from a 
polyacrylamide gel to a nitrocellulose membrane during 
semi- dry Western blotting (https://www.gelifesciences.com). 
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4.1.13  P. falciparum cultivation 
P. falciparum parasites were cultivated in human A+ or 0+ erythrocytes, obtained from the blood bank 
of the university hospitals in Marburg or Heidelberg. Parasites were incubated in petri dishes filled with 
cell culture medium at 37°C with a constant atmosphere of 90% N2, 5% CO2 and 5% O2 (Trager & 
Jensen 1976). Parasites were maintained at a parasitemia below 10% to prevent parasite death. 
𝑃𝑎𝑟𝑎𝑠𝑖𝑡𝑒𝑚𝑖𝑎 (%) =
𝑖𝑅𝐵𝐶𝑠
𝑛𝑅𝐵𝐶𝑠
∗ 100 
Standard cell culture media  Transfectant cell culture media 
One bottle RPMI 1640 (500 ml)  One bottle RPMI 1640 (500 ml) 
10 ml Hypoxanthine solution  10 ml Hypoxanthine solution  
5 ml Neomycin solution  5 ml Neomycin solution 
50 ml of Human plasma  50 ml of Human plasma 
 25 ml Albumax 
Human plasma  
Human plasma was obtained from the university hospitals in Marburg and Heidelberg. Frozen plasma 
was tawn overnight at 4°C and heat inactivated for 2 h at 50°C. Prior to use plasma was centrifuged at 
4500 g for 10 min, without brake and the supernatant was used for medium preparation. 
Albumax 
25 g AlbuMAXII in 500 ml RPMI 1640, sterile filtered. 
6 well plate  Small plate  
2 ml Media  12 ml Media  
80 µl Blood cells  500 µl Blood cells  
Big plate 
36 ml Media 
1.5 ml Blood cells 
 
4.1.14  Giemsa-smears 
4-6 µl of parasites culture (~2-3 µl of packed cells) were scraped from the bottom of a culture dish and 
spread evenly on a microscopy slide. The slide was then air dried, fixed with methanol for 5-10 
seconds and stained with Giemsa solution for 10-15 min. Parasitemia was determined with light 
microscopy at 1000x magnification using an oil immersion lens. 
Giemsa solution 
10% Giemsa (v/v) in H2O, filtered 
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4.1.15  Freezing of parasites 
For long- term storage 0,5 ml of packed RBCs with a parasitemia of ~ 5% ring-stage infected iRBCs 
were diluted 1:2 with freezing solution, transferred into a cryotube, shock- frozen in liquid nitrogen and 
kept in a -80°C freezer or liquid nitrogen for long-term storage (Snodgrass et al. 1975). 
 
Freezing solution 
28% (v/v) Glycerol 
3% (w/v) D-Sorbitol 
0.65% (w/v)  NaCl 
 
4.1.16  Thawing of P. falciparum parasites 
P. falciparum parasites cryopreserved in glycerol were tawn at 37°C in the water bath. Afterwards 
isotonicity was reconstituted through the drop- wise addition of 200 µl solution I, 5 ml solution II 5 ml 
solution III in three minute intervals with agitation of the tube (Snodgrass et al. 1975). Then parasites 
were pelleted (1600 g, 2 min), washed once with 10 ml of media and kept in routine cell culture. 
Thawing solution I  Thawing solution II 
12% NaCl (w/v) in ddH2O, sterile  1.2% NaCl (w/v) in ddH2O, steril 
Thawing solution III 
0.9% NaCl (w/v)  
0.2% (w/v) Glucose in ddH2O, sterile 
 
4.1.17  P. falciparum parasite synchronization via sorbitol- treatment 
Compared to the earlier ring-stages mature trophozoite stages of P. falciparum parasites exhibit an 
increased permeability to solutes (Staines et al. 2005). This can be used for synchronization of 
parasite cultures through sorbitol-induced lysis of late-stage parasites. Ring-stage parasites survive 
the sorbitol-treatment and thereafter form a more synchronous culture (Lambros & Vanderberg 1979). 
Parasite were harvested via centrifugation (1600 g, 2 min) and resuspended in 5 (small plate, ~ 500 µl 
of blood) or 10 (big plate, ~1500 µl of blood) ml pre-warmed sorbitol solution. After 10-15 min 
incubation at 37°C in the water bath parasites were washed once with 10 ml of media and re-seeded. 
Sorbitol solution 
5% (w/v) Sorbitol in ddH2O, sterile 
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4.1.18  Gelatine floatation 
Gelatine floatation allows enrichment of knob-forming, mature-stage P. falciparum iRBCs (Goodyer et 
al. 1994). Parasite cultures were harvested by centrifugation at 1600 g for 2 min. Parasites were 
resuspended in pre-warmed gelatine solution and incubated for 1 h at 37°C in a water bath. Then the 
supernatant (containing the enriched parasites) was carefully removed to a new tube and the pellet 
discarded. The supernatant was washed once with 10 ml medium (regular cell culture) or three-times 
with 10 ml cytoadhesion medium (for CSA binding selection or cytoadhesion assay) and re-seeded. 
Enrichment of the parasites was followed via Giemsa smears (See: 4.1.14). 
 
Gelatine solution 
Half a container of RPMI powder 8 g was solved in 400 ml of pre-warmed (up to 50°C) ddH2O. 
Following adjustment of the pH to 7.4 with NaOH 0.5% (w/v) of gelatine was added and sterile filtered 
after solving of the gelatine with a magnetic stirrer. 
 
4.1.19  P. falciparum parasite transfection 
Transgenic P. falciparum cell lines were generated via electroporation (Wu et al. 1995). For this 
~150 µg of plasmid were obtained via maxipreparation (See: 4.1.1), precipitated (See: 4.1.2), 
resuspended in 30 µl of pre-warmed TE and solved at 50°C for at least 10 min. Then 370 µl of pre-
warmed (37°C) cytomix was added and mixed with 200 µl packed cells of 5-15% ring-stage culture. 
This was transferred to a sterile cuvette (0.2 mm gap) and electroporation was executes at 310 kV, 
950 µF high capacitance (Fidock & Wellems 1997) with a time constant of ~8-4 ms. Transfected 
parasites were mixed with pre-warmed transfection media containing 400 µl fresh O+ blood and put 
into culture. 4-6 h after transfection the selective agent (WR f.c.: 2.5 nM or Blasticidin f.c.: 12 µg/ml) 
was added. Fresh transfectants were supplied daily with fresh media, fresh blood and selective agent 
until no more life parasites were seen in giemsa- stained smears (See: 4.1.14). During this stage 
parasites were also diluted, when necessary. When no more life parasites were seen in smears media 
was changed every 3-4 days until the transgenic parasites grew back. 
Cytomix 
25 mM HEPES 
2 mM EGTA 
80 mM KCl 
10 mM K2HPO4 
10 mM KH2PO4 
5 mM MgCl2 
150 µM CaCl2 
pH adjusted to 7.6 
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Fresh 0
+
 blood 
Fresh 0
+
 blood was pelleted for 10 min at 1600 g without brake. After removal of the supernatant cells 
were treated with 1:10 Citrate-phostphate-dextrose solution. 
 
4.1.20  Drug cycling 
Drug cycling refers to cultivation of transfectant P. falciparum lines with and without selective agent to 
achieve enrichment of integrant cell lines. In the absence of drug pressure plasmids are lost, while 
integrations into the genome are maintained. Drug cycling was executed in three three-week cycles off 
and on drug.  
 
4.1.21  Selection-linked-integration 
Selection-linked-integration is a new method to integrate a plasmid into the P. falciparum genome 
(Birnbaum et al. 2017). A typical plasmid carries a targeting region as well as two P. falciparum 
resistance markers. Firstly, a transfectants cell line is generated which carries the non-integrated 
plasmid via electroporation (See: 4.1.19) and the first resistance marker. The targeting region on the 
plasmid is designed to promote integration of the plasmid into the gene of interest via homologous 
recombination. Importantly, this targeting region does not feature a promotor to avoid expression from 
the plasmid. The second resistance marker is inserted in frame behind the coding region of the gene- 
of interest which couples expression of the second selective marker to integration of the plasmid into 
the genome. Separation of the gene of interest and the second resistance marker by a SKIP peptide 
sequence ensures production of two separate proteins from one open reading frame. For selection-
linked integration transfectants cell lines at a parasitemia of 1-2% were treated alongside the parental 
wild-type strain either with 400 µg/ml G418 or 12 µg/ml Blasticidin depending on the second resistance 
marker of the plasmid. Parasites were kept in 6 well-plates, fed daily and diluted when necessary until 
nor more life parasites could be seen. Then media was changed every 3-4 days until parasites re-
appeared.  
 
4.1.22  Limiting dilution 
Single clones of P. falciparum transgenic cell lines were obtained by limiting dilution. 23 ml of Media 
were mixed with 240 µl of blood and appropriate selective agents. To this heavily diluted parasites 
were added corresponding to ~34-35 total parasites. 200 µl of this mixture was spread into a 96 well 
plate which averages ~0.3 parasites/well. Media was changed ever 3-4 days for two weeks, then 
100 µl of the cultures were used to perform an LDH assay (See: 4.1.25) and identify wells with grown 
parasites. These likely originate from a single P. falciparum clone and were put into routine culture for 
further experiments. 
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Figure 72: Pathway allowing detection of pLDH via 
a colorimetric reaction in the LDH assay (modified 
from Markwalter et al.).  
4.1.23  Isolation of RBC-freed parasites via saponin-lysis 
The detergent saponin selectively lyses the plasma membrane of erythrocytes as well as the 
parasitophorous vacuole membrane surrounding the parasite but leaves internal parasites intact 
(Christophers & Fulton 1939). Saponin lysis was used to free parasites from the iRBC prior to gDNA 
extraction (See: 4.1.1). iRBCs were resuspended in 10 ml of PBS (pH 7.4) and 100 µl of freshly 
prepared 10% (w/v) saponin in PBS (pH 7.4) was added to initiate lysis for 8 min at RT. Then the freed 
parasites were pelleted by centrifugation at 4500 g for 3 min, washed once with 10 ml of PBS (pH 7.4) 
and used for gDNA extraction.  
 
4.1.24  Parasite purification via magnetic cell sorting (MACS) 
Accumulation of hemozoin renders late stage P. falciparum parasites magnetic (Staalsoe et al. 1999).  
This can be used to purify these stages via magnetic cell sorting. A CS-column was connected via a 
three-way stopcock to a needle and installed in the VarioMACS magnetic separator. After washing of 
the column with 10 ml of PBS (pH 7.4) and wash buffer the parasite culture was run though the CS 
column at a reduced flow rate (1-2 drops/sec). The first flow-through was collected and applied again 
to the column to increase yield. After washing of the column with ~30ml wash buffer, the column was 
removed from the magnetic separator and parasites were eluted using ~30 ml of PBS (pH 7.4).  
Wash buffer 
3% Bovine serum albumin (BSA) (w/v) in PBS (pH 7.4) 
 
4.1.25  pLDH-growth assay 
The P. falciparum enzyme lactate dehydrogenase (pLDH) converts pyruvate to lactate and reduces its 
cofactor NADH in this process (Basco et al. 1995). Contrary to the human LDH the plasmodial LDH 
can also utilize the NADH-like cofactor 3-acetylpyridine adenine dinucleotide (APAD) (Turgut-Balik et 
al. 2001). This enables researchers to detect parasite growth in a colorimetric assay. Firstly APAD is 
reduced by pLDH, which is then used via a second 
enzyme, diaphorase to convert a yellow dye 
(nitroblue tetrazolium) into its blue form (Figure 71, 
Markwalter et al. 2016). 100 µl of parasite culture 
were frozen over night at -20°C and then mixed with 
100 µl of LDH development solution. After incubation 
for 30 min in the dark at RT absorption at 650 nm 
was measured at an Biotek Cytation imaging reader. 
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Development solution  LDH buffer 
50 U/ml Diaphorase (Clostridium kluyveri)  0.1 M Tris/HCl 
75 µM APAD 50 mM Sodium L-Lactate 
In LDH buffer  0.25% Triton-X-100 
 1 NBT tablet/ 50ml 
 
4.1.26  CSA binding selection 
Since P. falciparum regularly undergoes switching of PfEMP1 variants (Biggs et al. 1991) with different 
binding capabilities to host cell receptors (Biggs et al. 1992), reliable cytoadhesion of P. falciparum 
iRBCs to the PfEMP1 ligand chondroitin sulphate A (CSA) requires regular selection of parasites 
expressing CSA binding PfEMP1 variants (Reeder et al. 1999). 10 ml of filter sterilized 1 mg/ml CSA in 
PBS (pH 7.2) was absorbed overnight to a tissue culture flask. On the following day the flask was 
washed three time with 10 ml PBS (pH 7.2) and blocked for 1 h with 10 ml of 1% BSA in PBS (pH 7.2) 
at RT. Mature stage parasites were enriched using gelatine floatation (See: 4.1.18) and, after washing 
of the flask with 10 ml of cytoadhesion medium, applied to the flask in 10 ml of cytoadhesion medium. 
Cytoadhesion was permitted for 1 h at RT. Then the flask was washed five times with 10 ml of 
Cytoadhesion media and gentle rocking. Bound iRBCs were removed from the flask by strong washing 
with a pipette boy and re-seeded. CSA binding selection was performed under sterile conditions and 
enrichment of the parasites was followed by Giemsa-stained smears (4.1.14) before and after gelatine 
floatation as well as after cytoadhesion. 
Cytoadhesion media: 
Half a tube of RPMI-powder (8 g) was dissolved in 400 ml of ddH2O. After adjustment of the pH to 7.2 
with NaOH the volume was adjusted to 500 ml and the medium was filter-sterilized. 
 
4.1.27  Chondroitin-Sulphate A (CSA) binding assay 
The Chondroitin-Sulphate A (CSA) binding assay allows assessment of the cytoadhesive capabilities 
of a P. falciparum cell lines to the PfEMP1 ligand CSA (Beeson et al. 1999). Purified ligand was 
dissolved in PBS (pH 7.2) to a final concentration of 1 mg/ml. Then 20 µl were applied in to marked, 
triplicate spots on a petri dish. A ligand-free control and a control with addition of the soluble ligand 
(1 mg/ml) to the parasites during the cytoadhesion phase of the assay (to demonstrate that the binding 
of the parasites in the assay is specific to CSA) were executed in parallel. The petri dish was then 
sealed with parafilm and absorption of the ligand to the petri dish was performed overnight at 16°C. 
On the following day each spot was washed three times with PBS (pH 7.2) and blocked with 1% BSA 
in PBS (pH 7.2). Mature-stage parasites were enriched via gelatine floatation (See: 4.1.18) and diluted 
to a concentration of 5x10
7
 iRBCs/ml in cytoadhesion- media. The blocked spots were washed once 
with 20 µl of cytoadhesion medium using a pipette. After application of 20 µl of the parasite 
suspensions cytoadhesion was allowed to occur for 1 h at RT. Then the non-bound RBCs and iRBCs 
were removed by washing once with a pipette followed flooding of the plate 12 ml of cytoadhesion 
medium and washing of the plate on an orbital shaker for 13 rounds at 70 rpm. Remaining 
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cytoadhesion medium was aspirated and the plate was washed once with 12 ml of PBS (without 
shaking). After this the plate was fixed with 12 ml of 2% glutaraldehyde in PBS (pH 7.2) for 1 h at RT. 
Following removal of remaining fixative the plate was washed twice with PBS (pH 7.2) and stained 
with filtered 10% Giemsa in ddH2O for 10 min at RT. After removal of the staining solution the plate 
was washed twice with PBS (pH 7.2), once with ddH2O and dried overnight. Parasites were counted 
microscopically: For each spot 14 pictures were taken in DIC with a 10x objective and 1,6x objectovar. 
Individual parasites were counted using two softwares: Ilastik and ImageJ. Ilastik was trained with 10 
diverse images to distinguish background and iRBCs. These were then counted by ImageJ. 
 
4.1.28  Immunofluorescence assay (IFA) 
IFA allows the investigation of the subcellular localization of proteins via specific antibodies in 
fluorescence microscopy. A primary antibody is directed against the protein of interest and detected 
with a fluorophore coupled secondary antibody directed against the primary antibody (Wickham et al. 
2001). Firstly parasites were spread on a microscopy slide, dried and fixed in a cuvette filled with 
fixation buffer for 5 min at -20°C. Slides were then blocked in blocking buffer for 1 h at RT and treated 
with the primary antibody in blocking buffer at 16°C overnight in a humid chamber. On the next day 
slides were washed three times with PBS (pH 7.4) and treated with the fluorophore- coupled 
secondary antibody directed against the primary antibody diluted 1:2000 in blocking buffer for 2 h at 
RT. The slides were then washed three times with PBS (pH 7.4) with 1 ng/ml DAPI in the second 
washing step to stain nuclei. After treatment of the slides with fluoromount and sealing with a coverslip 
slides were imaged at a Zeiss Axio-observer microscope and AxioVision software. 
Fixation buffer  Blocking buffer 
90% (v/v) Actetone  3% (w/v) BSA in PBS (pH 7.4) 
10% (v/v) Methanol 
 
4.1.29  Microfiltration (artificial spleen) 
P. falciparum iRBCs increasingly rigidify over the course of their life cycle, which affects their retention 
in the human spleen. While earlier ring-stages can perfuse through the spleen, later stages are more 
likely to be retained and destroyed. The heavy deformation displayed by RBCs crossing the 
interendothelial slits of the spleen can be mimicked by a layer of different-size metal microbeads, 
which can be used to asses iRBC rigidity via microfiltration (Deplaine et al. 2011). Since the rigidity of 
P. falciparum changes drastically during progression of the life cycle, stringent synchronization of the 
parasites is required (Figure 74). Parasites were first pre-synchronized by two sorbitol treatments 12 h 
apart. The resulting parasites were treated with 10 µM f.c. E-64 a protease inhibitor preventing 
schizont- rupture. The resulting PVM-enclosed merozoite structures (PEMPs) were purified from the 
culture via MACS, allowing rupture of the PEMPs and invasion by the resulting merozoites, this also 
allowed change of the whole blood in the culture for fresh blood. Merozoite-invasion was blocked after 
4 hours by addition of heparin (f.c. 0.3 U/ml). Artificial spleen assays were performed either 32 hours 
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after initiation of PEMPs rupture (28-32 hpi time 
point establishing experiments) or at 25-29 hpi 
(Upon PFA0660w regulation). In this experiment, 
highly synchronized iRBCs are perfused though an 
inverted filter tip which features a layer of different-
sized metal microbeads (Figure 73). Firstly, the tip 
of a 1 ml filter tip was cut and moistened with 200 µl 
of 70% Ethanol. Then 600 µl of freshly vortexed 
microbeads were added an allowed to settle. The 
filter tip was the connected to the pump and rinsed 
with 6 ml RPMI at 60 ml/h. Afterwards 
~1x10
8
 parasites suspended in plain RPMI 1640 
media were perfused through the artificial spleen 
and the downstream sample was collected. 
Retained cells were also obtained by collection of 
the supernatant after settling of the beads following 
inversion of the filter tip. Parasitemia in the 
upstream, downstream and retained sample was 
determined via giemsa smear or FACS analysis. 
Upstream and downstream parasitemia was then 
used to calculate the retention rate of the sample. 
𝑅𝑒𝑡𝑒𝑛𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 (%) =   1 − (
𝑃𝑎𝑟𝑎𝑠𝑖𝑡𝑒𝑚𝑖𝑎 𝑑𝑜𝑤𝑛𝑠𝑡𝑟𝑒𝑎𝑚
𝑃𝑎𝑟𝑎𝑠𝑖𝑡𝑒𝑚𝑖𝑎 𝑢𝑝𝑠𝑡𝑟𝑒𝑎𝑚
)𝑥100 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 73: Microfiltration setup. Parasite are 
perfused by a pump (I) through an inverted filter tip 
(II) featuring a layer of metal microbeads (III) into a 
collection tube (IV) 
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Figure 74: Synchronization workflow preceding artificial spleen assays. 
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4.1.30  Flow-cytometry with P. falciparum iRBCs 
In flow-cytometry cells are passed in single-file through a small capillary, which allows their 
examination of cell characteristics through a laser (Figure 75). Cell size can be judged by the forward 
scatter, while the side scatter allows investigation of the cells internal complexity. Also potential 
fluorophores can be excited and the resulting fluorescence can be detected via a set of filters and 
detectors. The resulting data is represented in a scatter blot. 1x10
7
-1x10
8
 cells were resuspended in 
100 µl of PBS (pH 7.4) and fixed with 200 µl of fixative at 4°C for 24 h. Cells were then pelleted at 
1000 g for 2 min, washed once with 200 µl of PBS (pH 7.4) and stained with DAPI (1 ng/ml) in 200 µl 
PBS (pH 7.4) for 10 min at RT. After washing of the cells three times with 200 µl of PBS (pH 7.4) cells 
were analysed with a BD Canto. The used gating strategy involved firstly gateing for RBCs, from these 
single cells were selected. DAPI positive red blood cells were interpreted as infected red blood cells, 
since human red blood cells are denuclated (Figure 76). Diva and Flow-Jo software were used for data 
analysis. 
  
Figure 75: During flow cytometry cell pass in single file through a capillary which enables their analysis by a 
laser. The data is processed and represented as a scatter-blot (https://www.thermofisher.com) 
Figure 76:  Gating strategy for determination of the parasitemia in a sample. 
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4.1.31  Scanning electron microscopy 
Scanning electron microscopy can be used to investigate structures on the surface of fixed cells. 
P. falciparum infected erythrocytes were purified via MACS (See: 4.1.24) and treated according to two 
differing downstream protocols: 
Marburg protocol (Protocol courtesy of Eric Gilles Hannsen from University of Melbourne) 
Approximately 1x10
8
 iRBCs were fixed overnight in 2.5% glutaraldehyde in PBS (pH 7.4) at 4°C. After 
washing four times with 1 ml of PBS (pH 7.4) cell were dehydrated in a series of 50%, 80% and 100% 
ethanol for 5 min each and twice in 100% acetone. Cells were then spotted onto a pin for electron 
microscopy, coated with platinum and imaged with a JSM-7500F scanning electron microscope. 
 
Heidelberg protocol 
Approximately 1x10
8
 iRBCs were fixed in 1 ml 1% glutaraldehyde in 1x PBS (Gibco pH 7.2) for 30 min 
at RT. After washing three times with 1 ml off 1x PBS (Gibco pH 7.2) 20 µl of the sample was spotted 
onto a coverslip which was coated with 20 µl of 0,1% polylysine for 15 min at RT. This was incubated 
for 15-20 min at RT and afterwards washed 3 times with 1x PBS (Gibco pH 7.2) and dehydrated in a 
series of ddH2O 25%, 50%, 75% and finally 100% acetone for 10 min each. The samples were then 
coated with 10 nm Au/Pd at a -10° angle and imaged with a Zeiss Lec15030 electron microscope.  
 
Preparation of the coverslips for the Heidelberg protocol 
Coverslips were washed with 40 ml of ddH2O for 2 min and sonicated, twice. Then coverslips were 
treated with 250 ml 0.1 N HCl for one hour on an orbital shaker and washed three times with ddH2O. 
Subsequently the coverslips were treated with 40 ml of 95% ethanol on an orbital shaker for 1 h, 
washed twice with ddH2O and stored in 95% ethanol. 
 
4.1.32 Transmission electron microscopy 
Transmission electron microscopy allows the investigation of intracellular structures via electron 
microscopy of embedded sections of cells. Cells were first fixed in fixation buffer I at 4°C overnight. 
After washing three times with 100 mM CaCo for 5 min cell were fixed a second time with fixation 
buffer II for 60 min at RT. Following washing twice with ddH2O cells were contrasted using 1% U-
acetate in ddH2O at 4°C overnight. On the next day cells were washed twice with ddH2O for 10 min at 
RT and dehydrated using 30%, 50%, 70%, 90% and twice 100% acetone in ddH2O for 10 min each. 
Cells were treated 25%, 50% and 75% trace levels at RT for 45 min and kept in 100% overnight until 
sections were prepared and imaged using a Jeol 1400 microscope.  
CaCo Buffer 
100 mM Sodium cacodylate 
Fixation buffer I      Fixation buffer II 
2% (v/v) Glutaraldehyde     1% (w/v) Osmium 
2% (w/v) Paraformaldeyhe     in CaCo buffer 
In Caco buffer 
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4.2 Materials 
4.2.1 Used Escherichia coli strains 
Strain Description Source 
TOP10 
F- mcrA Δ( mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ lacX74 recA1 araD139 Δ( 
araleu)7697 galU galK rpsL (StrR) endA1 nup 
Life Technologies 
PMC 103 mcrA Δ A(mcrBC-hsdRMS-mrr)102 recD sbcC Doherty et al 1993 
 
4.2.2 Used Plasmodium falciparum strains 
Strain Description Source 
CS2 
Laboratory isolate from the Brazilian ItG2F6 with 
high binding to HA and CSA due to expression of 
the PfEMP1 variant VAR2CSA (Beeson et al. 
2000). 
Beeson et al. 2000 
CS2(CSA) 
Obtained via re-selection of CS2 parasites for 
CSA binding. 
Generated during this project. 
FCR3(CSA) 
Clonal African isolate selected for CSA binding 
(Gadsden et al. 1985). 
Dr. Christine Lansche 
FCR3(ICAM) 
Clonal African isolate selected for ICAM binding 
(Gadsden et al. 1985). 
Dr. Christine Lansche 
CS2PFA66
glmS
 E11 
CS2(CSA) with the plasmid PFA0660w
glmS 
integrated into
 
the PFA0660w gene.
 
Clonal cell 
line. Enables GlcN dependent downregulation of 
PFA0660w. 
Generated during this project. 
CS2PFA66
M9
 C4 
CS2(CSA) with the plasmid PFA0660w
M9
 
integrated into
 
the PFA0660w gene.
 
Clonal cell 
line. 
Generated during this project. 
CS2G18
glmS
 
CS2(CSA) with the plasmid GEXP18
glmS
 
integrated into
 
the GEXP18 gene. 
Generated during this project. 
CS2G18
M9
 
CS2(CSA) with the plasmid GEXP18
M9
 
integrated into
 
the GEXP18 gene. 
Generated during this project. 
CS2PfJ23
glmS
 
CS2(CSA) with the plasmid PFJ23
glmS 
integrated 
into
 
the PfJ23 gene. Enables GlcN dependent 
downregulation of PfJ23. 
Generated during this project. 
CS2PfJ23
M9
 
CS2(CSA) with the plasmid PfJ23
M9
 integrated 
into
 
the PfJ23 gene. 
Generated during this project. 
CS2CBP1
glmS
 
CS2(CSA) with the plasmid CBP1
glmS 
integrated 
into
 
the CBP1 gene. Enables GlcN dependent 
downregulation of CBP1. 
Generated during this project. 
CS2CBP1
M9
 
CS2(CSA) with the plasmid CBP1
M9
 integrated 
into
 
the CBP1 gene. 
Generated during this project. 
CS2∆PFA0660w SBD  
CS2(CSA) with the plasmid ∆PFA0660w SBD
 
integrated into
 
the PFA0660w gene, leading to 
truncation of the substrate binding domain of 
PFA0660w. 
Generated during this project. 
 
4.2.3 Biological reagents 
Reagent  Supplier (Location) 
KOD hot start polymerase  Novagen (St. Louis) 
Antarctic phosphatase New England Biolabs (Ipswich) 
T4 Ligase Life technologies (Carlsbad) 
α-GFP (Mouse) Roche (Basel) 
α-GFP (Chicken) Abcam (Cambridge) 
α-SERP (rabbit) PD. Dr. Jude Przyborski 
α-GLYCO AB (mouse) Sigma Aldrich (Taufkirchen) 
α-EXP1 (rabbit) PD. Dr. Jude Przyborski 
α-mouse-HRP (goat) Dako (Jena) 
α-rabbit-HRP (goat) Dako (Jena) 
α-PfEMP1 (rabbit) PD. Dr. Jude Przyborski 
α-PfEMP3  PD. Dr. Jude Przyborski 
α-KAHRP (rabbit) PD. Dr. Jude Przyborski 
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α-PHIST A(rabbit) PD. Dr. Jude Przyborski 
α-PfHSP70x  PD. Dr. Jude Przyborski 
α-EXP2 (rabbit) PD. Dr. Jude Przyborski 
α-SBP1 BR5 (rabbit) Prof. Dr. Catherine Braun- Beton 
α-REX2 (rabbit) PD. Dr. Jude Przyborski 
α-chicken-Cy2 (goat) Dako (Jena) 
α-mouse-Cy3 (goat) Dako (Jena) 
α-rabbit-Cy3 (goat) Dako (Jena) 
dNTPs Peqlab (Erlangen) 
Restriction enzymes: NheI, EcoRI, NotI, XhoI, AvrII, 
MluI 
New England Biolabs (Ipswich) 
 
4.2.4 Oligonucleotides 
Description 5´-3´ Sequence 
GFP_54_R GTGCCCATTAACATCACCATC 
Not-70_F GGCGGATAACAATTTCACACAGG 
PFA0660w_5´_F GACTTATTGAACTGCGGTTATATTATAAAG 
PFA0660w_3´_R GTATGCAAATCATAATAAATTCATATATC 
CBP1_5´_F TTGCACAATGTCCTTTTGTTACGTTAG 
CBP1_3´_R AAATATATATTACTCTTCAACTTATTAAAGTTTAATAGG 
GEXP18_5´_F TTTGAAAGTTATTAGTTTTGGGTTGTTTG 
GEXP18_3´_R TACATTTATCCATATACATTCCATTTTTGTGC 
PfJ23_5´_F CTTTTACAATGTTATTATTAAAAAGAATATTATGATAAAAG 
PfJ23_3´_R CATATATTTACCTTATAAGTAATAAATCAAATTAGTC 
PFA0660w_NotI_F CAGCGGCCGCAACCTTAAGGAAAAGCTATG 
PFA0660w_MluI_R ATACGCGTAGTAAATATATTATGATTTCCAGCAC 
H70_F ATGGCTAGTGCAAAAGGTTCAAAAC 
H70_R GCTGGAACGGTAATGACAGCATTC 
SBP1_F CCCTCGAGATGTGTAGCGCAGCCCGAGCATTTG 
SBP1_R CCCCTAGGGGTTTCTCTAGCAACTGTTTTT 
KAHRP_F GGCTCGAGATGAAAAGTTTTAAGAACAAAAATACTT 
KAHRP_R GGCCTAGGACCACAGCATCCTCTTTTCTTC 
KAHSP40_F AGCTATGAAGTGGCACCC 
KAHSP40_R AATTGTCGTACCATCACACC 
 
4.2.5 Plasmids 
Description 
Resistance Marker 
Source 
E. coli P. falciparum 
PFA0660w
glmS
 Amp hDHFR Wiebke Fleck 
PFA0660w
M9
 Amp hDHFR Wiebke Fleck 
GEXP18
glmS
 Amp hDHFR, BSD Jessica Kimmel 
GEXP18
M9
 Amp hDHFR, BSD Jessica Kimmel 
CBP1
glmS
 Amp hDHFR, BSD Jessica Kimmel 
CBP1
M9
 Amp hDHFR, BSD Jessica Kimmel 
PfJ23
glmS
 Amp hDHFR, BSD Jessica Kimmel 
PfJ23
M9
 Amp hDHFR, BSD Jessica Kimmel 
pSLI-TGD Amp NeoR, BSD Dr. Tobias Spielmann 
∆PFA0660w SBD Amp NeoR, BSD Cloning 
 
4.2.6 Chemicals 
Description Supplier (Location) 
Acetic acid Merck (Darmstadt) 
Acetone Merck (Darmstadt) 
Acrylamide Roth (Karlsruhe) 
AlbuMAXII Invitrogen (Groningen) 
APAD Sigma Aldrich (Taufkirchen) 
APS Roth (Karlsruhe) 
Blasticidin Invivo Gen (Toulouse) 
Bromophenolblue GE healthcare (Chicago) 
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BSA Roth (Karlsruhe) 
CaCl2 Roth (Karlsruhe) 
Cresol red Sigma Aldrich (Taufkirchen) 
CSA Sigma Aldrich (Taufkirchen) 
CTA Sigma Aldrich (Taufkirchen) 
DAPI Roth (Karlsruhe) 
Diaphorase Sigma Aldrich (Taufkirchen) 
DTT Applichem (Chicago) 
Glycine Sigma Aldrich (Taufkirchen) 
E-64 Sigma Aldrich (Taufkirchen) 
EDTA Roth (Karlsruhe) 
EGTA Roth (Karlsruhe) 
Ethanol VWR (Radnor) 
G418 Thermo Fisher Scientific (Waltham) 
Gelatine Sigma Aldrich (Taufkirchen) 
Giemsa Merck (Darmstadt) 
Glucose Roth (Karlsruhe) 
Glutaraldehyde Roth (Karlsruhe) 
Glycerol Roth (Karlsruhe) 
HCl Roth (Karlsruhe) 
Heparin Sigma Aldrich (Taufkirchen) 
HEPES Roth (Karlsruhe) 
Hypoxanthine C.C. Pro (Oberdorla) 
1 kb + DNA size- standard Thermo Fisher Scientific (Waltham) 
K2HPO4 Roth (Karlsruhe) 
KCl Roth (Karlsruhe) 
KH2PO4 Roth (Karlsruhe) 
Luminol Applichem (Chicago) 
Methanol VWR (Radnor) 
MgCl2 Roth (Karlsruhe) 
MgSO4 Roth (Karlsruhe) 
Milk powder Roth (Karlsruhe) 
NaCl Roth (Karlsruhe) 
NaOH Roth (Karlsruhe) 
NBT tablets Sigma Aldrich (Taufkirchen) 
Neomycin Sigma Aldrich (Taufkirchen) 
(NH4)2SO4 Roth (Karlsruhe) 
PageRuler Prestained Protein Ladder Thermo Fisher Scientific (Waltham) 
Paraformaldehyde Roth (Karlsruhe) 
P-coumaric acid Sigma Aldrich (Taufkirchen) 
Peptone Roth (Karlsruhe) 
Ponceau S blubs Roth (Karlsruhe) 
RPMI 1640 Life technologies (Carlsbad) 
RPMI- powder Life technologies (Carlsbad) 
Saponin Roth (Karlsruhe) 
SDS Roth (Karlsruhe) 
Super optimal broth Roth (Karlsruhe) 
Sodium L-Lactate Roth (Karlsruhe) 
Sorbitol Roth (Karlsruhe) 
TEMED Roth (Karlsruhe) 
Tris Roth (Karlsruhe) 
Triton-X-100 Roth (Karlsruhe) 
Yeast extract Roth (Karlsruhe) 
 
4.2.7 Plastic ware 
Description Supplier (Location) 
Cell culture petri dishes Sarstedt (Nümbrecht) 
6 well plates Sarstedt (Nümbrecht) 
96 well plates flat/ U- bottom Sarstedt (Nümbrecht) 
Plastic pipettes 25, 10, 5, 2 ml Sarstedt (Nümbrecht) 
Pipette tips 1000, 200, 10 µl Sarstedt (Nümbrecht) 
Petri dishes: CSA binding  Corning (New York) 
E. coli petri dishes  Sarstedt (Nümbrecht) 
50, 15 ml Falcons Corning (New York) 
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Eppendorf cups 2 and 1,5 ml Sarstedt (Nümbrecht) 
PCR cups and stripes Sarstedt (Nümbrecht) 
Cell culture flasks Sarstedt (Nümbrecht) 
Filter tip for artificial spleens 1000 µl VWR (Radnor) 
Metal microbeads IPS, spherical powder industries (Annemasse) 
Glass- pipettes VWR (Radnor) 
Glass- slides VWR (Radnor) 
Medical X-Ray film Fujifilm (Minator) 
 
4.2.8 Kits 
Description Supplier (Location) 
Plasmid Miniprep Kit I Peqlab (Erlangen) 
PeqGOLD Gel extraction kit Peqlab (Erlangen) 
PeqGOLD, Cycle pure kit Peqlab (Erlangen) 
Plasmid Maxi Kit Qiagen (Hilden) 
DNA Mini kit Qiagen (Hilden) 
 
4.2.9 Equipment 
Description Model 
Transmission electron microscope Jeol 1400 
Scanning electron microscope  Zeiss Leo15030 
Microtome Leica UC6 
Flow cytometer BD Canto 
Magnetic cell sorter Milyenti Biotech Magnetic cell sorter 
Incubator Labotech Inkubator C200 
Water bath ThermoScientific Precision GP10 
Centrifuges Hettich Mikro 220R, Heraeus Labofuge 400e, SORVAll 
RC 5B Plus, Beckman J2-MC 
Pump Pharmacia Biotech, Pump P-1 
Light microscope KernOptics 
Fluorescent microscope Zeiss Axio-observer 
Sterile Workbench ThermoScientific, HERAsafeKS 
Pipetboy IntegraBioscience 
Freezer ThermoScientific Herafreeze top 
Fridge Liebherr 
PCR- Cycler Eppendorf Mastercylcer gradient 
Heating block Eppendorf Thermomixer 5436 
Pipettes Gilson 
Spectrometer UVIKON 923 Double beam UV/VIS spectrometer 
Shaker Heidolph UNIMAX1010 
Roller MAGV, TRM50 
Plate reader Biotek Cytation Imaging reader 
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